FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Harry Büller

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Co-author Network

Publications

TOP 3
Danka J F Stuijver; Bregje van Zaane; Christof J Majoor; Patrick C Souverein; Harry R Büller; Anthonius de Boer; Olaf M Dekkers; Victor E A Gerdes
Use of oral glucocorticoids and the risk of pulmonary embolism: a population-based case-control study.
J van Es; Peter Verhamme; P S Wells; Henri Bounameaux; R A Douma; V E A Gerdes; Pieter W Kamphuisen; A W A Lensing; Harry R Büller
Clot resolution after 3 weeks of anticoagulant treatment for pulmonary embolism: comparison of computed tomography and perfusion scintigraphy.
Alexander T Cohen; Lloyd Haskell; Dayi Hu; Russell Hull; Alexandre Mebazaa; Geno Merli; Sebastian Schellong; Theodore E Spiro; Alex C Spyropoulos; Victor F Tapson; Harry R Büller
Rivaroxaban for thromboprophylaxis in acutely ill medical patients.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Harry Büller (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Danka J F Stuijver; Bregje van Zaane; Christof J Majoor; Patrick C Souverein; Harry R Büller; Anthonius de Boer; Olaf M Dekkers; Victor E A Gerdes
Use of oral glucocorticoids and the risk of pulmonary embolism: a population-based case-control study.
Chest 2013;143(5):1337-42.
2013: J van Es; Peter Verhamme; P S Wells; Henri Bounameaux; R A Douma; V E A Gerdes; Pieter W Kamphuisen; A W A Lensing; Harry R Büller
Clot resolution after 3 weeks of anticoagulant treatment for pulmonary embolism: comparison of computed tomography and perfusion scintigraphy.
Journal of thrombosis and haemostasis : JTH 2013;11(4):679-85.
2013: Alexander T Cohen; Lloyd Haskell; Dayi Hu; Russell Hull; Alexandre Mebazaa; Geno Merli; Sebastian Schellong; Theodore E Spiro; Alex C Spyropoulos; Victor F Tapson; Harry R Büller
Rivaroxaban for thromboprophylaxis in acutely ill medical patients.
The New England journal of medicine 2013;368(6):513-23.
2013: Wim A M Lucassen; Cornelia M Schaefer-Prokop; Inge A H van den Berk; Ludo F M Beenen; Harry R Büller; Petra M G Erkens; Henk C P M van Weert
Concerns in using multi-detector computed tomography for diagnosing pulmonary embolism in daily practice. A cross-sectional analysis using expert opinion as reference standard.
Thrombosis research 2013;131(2):145-9.
2012: Elise S Eerenberg; Marcel Levi; Harry R Büller
Contra: "Antidotes for novel anticoagulants?"--Do we really need them.
Thrombosis and haemostasis 2012;108(4):623-4.
2012: Alex KleinJan; Martin H Prins; F F van Doormaal; Harry R Büller; J M M B Otten
Limitations of screening for occult cancer in patients with idiopathic venous thromboembolism.
The Netherlands journal of medicine 2012;70(7):311-7.
2012: Frederiek van Doormaal; Dick J Richel; Augueste Sturk; René J Berckmans; Harry R Büller; Pieter W Kamphuisen; Alex KleinJan; Nigel Mackman; David Manly; Rienk Nieuwland
Coagulation activation and microparticle-associated coagulant activity in cancer patients. An exploratory prospective study.
Thrombosis and haemostasis 2012;108(1):160-5.
2012: Giancarlo Agnelli; Scott Darrell Berkowitz; Henri Bounameaux; Harry R Büller; Jaromir Chlumsky; Alexander Cohen; Bruce L Davidson; Hervé Decousus; Alex S Gallus; Barry F Jacobson; Anthonie W A Lensin; Erich Minar; Frank Misselwitz; Martin H Prins; Gary E Raskob; Sebastian Schellong; Peter Verhamme; Phil Wells; Annelise Segers
Oral rivaroxaban for the treatment of symptomatic pulmonary embolism.
The New England journal of medicine 2012;366(14):1287-97.
2012: A J ten Cate-Hoek; Diane B Toll; E F van der Velde; H C P M van Weert; Harry R Büller; A W Hoes; Manuela A Joore; K G M Moons; Ruud Oudega; Martin H Prins; Henri ('Jelle') Stoffers
Common alternative diagnoses in general practice when deep venous thrombosis is excluded.
The Netherlands journal of medicine 2012;70(3):130-5.
2012: Danny M Cohn; J Hans DeVries; Jeroen Hermanides; J B L Hoekstra; Martin Homering; Pieter W Kamphuisen; Silvia Kuhls; Anthonie W A Lensing; Harry R Büller
Stress-induced hyperglycaemia and venous thromboembolism following total hip or total knee arthroplasty: analysis from the RECORD trials.
Thrombosis and haemostasis 2012;107(2):225-31.
2012: Harry R Büller; Alex S Gallus; Gerard Pillion; Martin H Prins; Gary E Raskob
Enoxaparin followed by once-weekly idrabiotaparinux versus enoxaparin plus warfarin for patients with acute symptomatic pulmonary embolism: a randomised, double-blind, double-dummy, non-inferiority trial.
Lancet 2012;379(9811):123-9.
2012: Petra M G Erkens; Harry R Büller; Hugo ten Cate; Martin H Prins
Benchmark for time in therapeutic range in venous thromboembolism: a systematic review and meta-analysis.
PloS one 2012;7(9):e42269.
2012: Geert-Jan Geersing; Arno W Hoes; Wim A M Lucassen; Karel G M Moons; Ruud Oudega; Martin H Prins; Harry R Büller; Hugo ten Cate; Petra M G Erkens; Henk C P M van Weert; Henri ('Jelle') Stoffers
Safe exclusion of pulmonary embolism using the Wells rule and qualitative D-dimer testing in primary care: prospective cohort study.
BMJ (Clinical research ed.) 2012;345():e6564.
2012: B L W Bendermacher; Harry R Büller; Machteld Langenberg; Ron J G Peters; Joep A W Teijink; Edith M Willigendael; Marie-Louise E L Bartelink; Martin H Prins
Applicability of the ankle-brachial-index measurement as screening device for high cardiovascular risk: an observational study.
BMC cardiovascular disorders 2012;12():59.
2011: Elise S Eerenberg; Meertien K Sijpkens; Josien van Es; Harry R Büller; Pieter W Kamphuisen
New anticoagulants: moving on from scientific results to clinical implementation.
Annals of medicine 2011;43(8):606-16.
2011: B Van Zaane; A P Van Zanten; Harry R Büller; suzanne cannegieter; J Debeij; Olaf M Dekkers; V E A Gerdes; J C M Meijers; Alessandro Squizzato; D P M Brandjes
Alterations in coagulation and fibrinolysis after levothyroxine exposure in healthy volunteers: a controlled randomized crossover study.
Journal of thrombosis and haemostasis : JTH 2011;9(9):1816-24.
2011: Elizabeth F W van Vlijmen; Nic J G M Veeger; Harry R Büller; Karly Hamulyák; Saskia Middeldorp; Martin H Prins; Karina Meijer
Thrombotic risk during oral contraceptive use and pregnancy in women with factor V Leiden or prothrombin mutation: a rational approach to contraception.
Blood 2011;118(8):2055-61; quiz 2375.
2011: Theodore E Warkentin; Harry R Büller; Bruce L Davidson; Alexander Gallus; Michael Gent; Anthonie W A Lensing; Franco Piovella; Martin H Prins; A E M Segers; John G Kelton
Prevalence and risk of preexisting heparin-induced thrombocytopenia antibodies in patients with acute VTE.
Chest 2011;140(2):366-73.
2011: M van Wissen; Harry R Büller; V E A Gerdes; Tymen T Keller; J C M Meijers; G J J van Doornum; Eric C M van Gorp; D P M Brandjes
Acute respiratory tract infection leads to procoagulant changes in human subjects.
Journal of thrombosis and haemostasis : JTH 2011;9(7):1432-4.
2011: Deirdre A Lane; Harry R Büller; Pieter W Kamphuisen; Pascal Minini; Gregory Y H Lip
Bleeding risk in patients with atrial fibrillation: the AMADEUS study.
Chest 2011;140(1):146-55.
2011: Renée A Douma; Marc F Durian; Petra M G Erkens; Herman M A Hofstee; Marcel M Hovens; Menno V Huisman; Pieter W Kamphuisen; Frederikus A Klok; Inge C M Mos; Tessa A C Nizet; Hugo ten Cate; Erik F Ullmann; Anja A van Houten; Harry R Büller
Performance of 4 clinical decision rules in the diagnostic management of acute pulmonary embolism: a prospective cohort study.
Annals of internal medicine 2011;154(11):709-18.
2011: Olav R de Peuter; Gregory Y H Lip; Patrick C Souverein; Olaf Klungel; Anthonius de Boer; Harry R Büller; Pieter W Kamphuisen
Time-trends in treatment and cardiovascular events in patients with heart failure: a pharmacosurveillance study.
European journal of heart failure 2011;13(5):489-95.
2011: Rachel E J Roach; Sara Roshani; Karina Meijer; Karly Hamulyák; Willem M Lijfering; Martin H Prins; Harry R Büller; Saskia Middeldorp
Risk of cardiovascular disease in double heterozygous carriers and homozygous carriers of F5 R506Q (factor V Leiden) and F2 (prothrombin) G20210A: a retrospective family cohort study.
British journal of haematology 2011;153(1):134-6.
2011: S Biere-Rafi; B W Haak; Marjolein Peters; V E A Gerdes; Harry R Büller; Pieter W Kamphuisen
The impairment in daily life of obese haemophiliacs.
Haemophilia : the official journal of the World Federation of Hemophilia 2011;17(2):204-8.
2011: Bregje van Zaane; Alessandro Squizzato; Anne Q Reuwer; Anton P Van Zanten; Marcel T B Twickler; Olaf M Dekkers; suzanne cannegieter; Harry R Büller; Victor E A Gerdes; Dees P M Brandjes
Prolactin and venous thrombosis: indications for a novel risk factor?
Arteriosclerosis, thrombosis, and vascular biology 2011;31(3):672-7.
2011: Alessandro Squizzato; Bregje Van Zaane; V E A Gerdes; Harry R Büller
The influence of pituitary, adrenal, and parathyroid hormones on hemostasis and thrombosis.
Seminars in thrombosis and hemostasis 2011;37(1):41-8.
2011: Sara Biere-Rafi; Manuel A Baarslag; Marjolein Peters; Marieke J H A Kruip; Roderik A Kraaijenhagen; Martin Den Heijer; Harry R Büller; Pieter W Kamphuisen
Cardiovascular risk assessment in haemophilia patients.
Thrombosis and haemostasis 2011;105(2):274-8.
2011: Olav R de Peuter; Patrick C Souverein; Olaf Klungel; Harry R Büller; Anthonius de Boer; Pieter W Kamphuisen
Non-selective vs. selective beta-blocker treatment and the risk of thrombo-embolic events in patients with heart failure.
European journal of heart failure 2011;13(2):220-6.
2011: Sara Roshani; Alexander C Stehouwer; Joris A M van der Post; Hans Wolf; Harry R Büller; Danny M Cohn; Pieter W Kamphuisen; Saskia Middeldorp
Incidence of postpartum haemorrhage in women receiving therapeutic doses of low-molecular-weight heparin: results of a retrospective cohort study.
BMJ open 2011;1(2):e000257.
2011: S Roshani; W M Lijfering; Michiel Coppens; Karly Hamulyák; Martin H Prins; Harry R Büller; Saskia Middeldorp
Risk factors of arterial cardiovascular complications in patients with prior venous thromboembolism.
The Netherlands journal of medicine 2011;69(1):27-30.
2011: Eit Frits van der Velde; Diane B Toll; Arina J Ten Cate-Hoek; Ruud Oudega; Henri ('Jelle') Stoffers; Patrick M Bossuyt; Harry R Büller; Martin H Prins; Arno W Hoes; Karel G M Moons; Henk C P M van Weert
Comparing the diagnostic performance of 2 clinical decision rules to rule out deep vein thrombosis in primary care patients.
Annals of family medicine 2011;9(1):31-6.
2011: Michael W T Tanck; Iris M Wichers; Joost C M Meijers; Harry R Büller; Pieter H Reitsma; Saskia Middeldorp
Quantitative trait locus for protein C in a family with thrombophilia.
Thrombosis and haemostasis 2011;105(1):199-201.
2011: F F Van Doormaal; W Terpstra; René van der Griend; Martin H Prins; Marten Nijziel; Marcel A van de Ree; Harry R Büller; J C Dutilh; A ten Cate-Hoek; S M Van Den Heiligenberg; Jan van der Meer; J M Otten
Is extensive screening for cancer in idiopathic venous thromboembolism warranted?
Journal of thrombosis and haemostasis : JTH 2011;9(1):79-84.
2011: Kristel J M Janssen; Eit F van der Velde; Arina J Ten Cate; Martin H Prins; Henk C P M van Weert; Henri ('Jelle') Stoffers; Harry R Büller; Ruud Oudega; Arno Hoes; Diane B Toll; Karel G M Moons
Optimisation of the diagnostic strategy for suspected deep-vein thrombosis in primary care.
Thrombosis and haemostasis 2011;105(1):154-60.
2010: M C Struijk-Mulder; W van Wijhe; Y K Sze; S Knollema; C C Verheyen; Harry R Büller; W M Fritschy; Harmen B Ettema
Death and venous thromboembolism after lower extremity amputation.
Journal of thrombosis and haemostasis : JTH 2010;8(12):2680-4.
2010: Josien van Es; Renée A Douma; V E A Gerdes; Pieter W Kamphuisen; Harry R Büller
Acute pulmonary embolism. Part 2: treatment.
Nature reviews. Cardiology 2010;7(11):613-22.
2010: B van Zaane; E Nur; Alessandro Squizzato; V E A Gerdes; Harry R Büller; O M Dekkers; D P M Brandjes
Systematic review on the effect of glucocorticoid use on procoagulant, anti-coagulant and fibrinolytic factors.
Journal of thrombosis and haemostasis : JTH 2010;8(11):2483-93.
2010: Renée A Douma; Geerte L van Sluis; Pieter W Kamphuisen; Maaike Söhne; Frank W G Leebeek; Patrick M M Bossuyt; Harry R Büller
Clinical decision rule and D-dimer have lower clinical utility to exclude pulmonary embolism in cancer patients. Explanations and potential ameliorations.
Thrombosis and haemostasis 2010;104(4):831-6.
2010: Renée A Douma; Pieter W Kamphuisen; Harry R Büller
Acute pulmonary embolism. Part 1: epidemiology and diagnosis.
Nature reviews. Cardiology 2010;7(10):585-96.
2010: Frederiek F van Doormaal; Harry R Büller
Heparin and survival in cancer patients.
Hematology/oncology clinics of North America 2010;24(4):777-84, ix-x.
2010: Frederiek F van Doormaal; Alexander T Cohen; Bruce L Davidson; Hervé Decousus; Alexander Gallus; Michael Gent; Franco Piovella; Martin H Prins; Gary E Raskob; Harry R Büller
Idraparinux versus standard therapy in the treatment of deep venous thrombosis in cancer patients: a subgroup analysis of the Van Gogh DVT trial.
Thrombosis and haemostasis 2010;104(1):86-91.
2010: Bregje van Zaane; Alessandro Squizzato; Roeland Huijgen; Anton P Van Zanten; Eric Fliers; Suzanne C Cannegieter; Harry R Büller; V E A Gerdes; D P M Brandjes
Increasing levels of free thyroxine as a risk factor for a first venous thrombosis: a case-control study.
Blood 2010;115(22):4344-9.
2010: Renée A Douma; Maayke G M Kok; Lisa M Verberne; Pieter W Kamphuisen; Harry R Büller
Incidental venous thromboembolism in cancer patients: prevalence and consequence.
Thrombosis research 2010;125(6):e306-9.
2010: Anja B U Mäkelburg; Nic J G M Veeger; Saskia Middeldorp; Karly Hamulyák; Martin H Prins; Harry R Büller; Willem M Lijfering
Different risk of deep vein thrombosis and pulmonary embolism in carriers with factor V Leiden compared with non-carriers, but not in other thrombophilic defects. Results from a large retrospective family cohort study.
Haematologica 2010;95(6):1030-3.
2010: S Biere-Rafi; M Zwiers; M Peters; Jan van der Meer; Frits R Rosendaal; Harry R Büller; P W Kamphuisen
The effect of haemophilia and von Willebrand disease on arterial thrombosis: a systematic review.
The Netherlands journal of medicine 2010;68(5):207-14.
2010: A J M Schreijer; M F Hoylaerts; Joost C M Meijers; H R Lijnen; Saskia Middeldorp; Harry R Büller; Pieter H Reitsma; Frits R Rosendaal; suzanne cannegieter
Explanations for coagulation activation after air travel.
Journal of thrombosis and haemostasis : JTH 2010;8(5):971-8.
2010: Stef P Kaandorp; Mariëtte Goddijn; Joris A M van der Post; Barbara A Hutten; Harold R Verhoeve; Karly Hamulyák; Ben Mol; Nienke Folkeringa; Marleen Nahuis; Dimitri N M Papatsonis; Harry R Büller; Fulco van der Veen; Saskia Middeldorp
Aspirin plus heparin or aspirin alone in women with recurrent miscarriage.
The New England journal of medicine 2010;362(17):1586-96.
2010: Willem M Lijfering; Saskia Middeldorp; Nic J G M Veeger; Karly Hamulyák; Martin H Prins; Harry R Büller; Jan van der Meer
Risk of recurrent venous thrombosis in homozygous carriers and double heterozygous carriers of factor V Leiden and prothrombin G20210A.
Circulation 2010;121(15):1706-12.
2010: Geerte L van Sluis; Harry R Büller; C Arnold Spek
The role of activated protein C in cancer progression.
Thrombosis research 2010;125 Suppl 2():S138-42.
2010: Nadine S Gibson; Renee A Douma; Alessandro Squizzato; Maaike Söhne; Harry R Büller; V E A Gerdes
Application of a decision rule and a D-dimer assay in the diagnosis of pulmonary embolism.
Thrombosis and haemostasis 2010;103(4):849-54.
2010: M C Struijk-Mulder; Harmen B Ettema; C C Verheyen; Harry R Büller
Comparing consensus guidelines on thromboprophylaxis in orthopedic surgery.
Journal of thrombosis and haemostasis : JTH 2010;8(4):678-83.
2010: F A Klok; D M Cohn; Saskia Middeldorp; Margreet Scharloo; Harry R Büller; Klaas W van Kralingen; Adrian A Kaptein; Menno V Huisman
Quality of life after pulmonary embolism: validation of the PEmb-QoL Questionnaire.
Journal of thrombosis and haemostasis : JTH 2010;8(3):523-32.
2010: D M Cohn; S Repping; Harry R Büller; J C M Meijers; Saskia Middeldorp
Increased sperm count may account for high population frequency of factor V Leiden.
Journal of thrombosis and haemostasis : JTH 2010;8(3):513-6.
2010: Wim A M Lucassen; Renée A Douma; Diane B Toll; Harry R Büller; Henk C P M van Weert
Excluding pulmonary embolism in primary care using the Wells-rule in combination with a point-of care D-dimer test: a scenario analysis.
BMC family practice 2010;11():64.
2010: Renée A Douma; Grégoire LE GAL; Maaike Söhne; Marc Righini; Pieter W Kamphuisen; Arnaud Perrier; Marieke J H A Kruip; Henri Bounameaux; Harry R Büller; Pierre-Marie Roy
Potential of an age adjusted D-dimer cut-off value to improve the exclusion of pulmonary embolism in older patients: a retrospective analysis of three large cohorts.
BMJ (Clinical research ed.) 2010;340():c1475.
2010: Frederiek F van Doormaal; Selma Atalay; Henk J Brouwer; Eit-Frits van der Velde; Harry R Büller; Henk C P M van Weert
Idiopathic superficial thrombophlebitis and the incidence of cancer in primary care patients.
Annals of family medicine 2010;8(1):47-50.
2010: Renée A Douma; Herman M A Hofstee; Cornelia Schaefer-Prokop; Jan-Hein T M van Waesberghe; Rutger J Lely; Pieter W Kamphuisen; V E A Gerdes; Mark H H Kramer; Harry R Büller
Comparison of 4- and 64-slice CT scanning in the diagnosis of pulmonary embolism.
Thrombosis and haemostasis 2010;103(1):242-6.
2009: Eefje Jong; Susan Louw; Joost C M Meijers; Martijn D de Kruif; Hugo ten Cate; Harry R Büller; Jan Willem Mulder; Eric C M van Gorp
The hemostatic balance in HIV-infected patients with and without antiretroviral therapy: partial restoration with antiretroviral therapy.
AIDS patient care and STDs 2009;23(12):1001-7.
2009: O R de Peuter; Federico Lussana; R J G Peters; Harry R Büller; P W Kamphuisen
A systematic review of selective and non-selective beta blockers for prevention of vascular events in patients with acute coronary syndrome or heart failure.
The Netherlands journal of medicine 2009;67(9):284-94.
2009: Willem M Lijfering; Nic J G M Veeger; Saskia Middeldorp; Karly Hamulyák; Martin H Prins; Harry R Büller; Jan van der Meer
A lower risk of recurrent venous thrombosis in women compared with men is explained by sex-specific risk factors at time of first venous thrombosis in thrombophilic families.
Blood 2009;114(10):2031-6.
2009: T M H Niers; L W Brüggemann; G L VAN Sluis; R D Liu; H H Versteeg; Harry R Büller; C J F VAN Noorden; Pieter H Reitsma; C A Spek; Dick J Richel
Long-term thrombin inhibition promotes cancer cell extravasation in a mouse model of experimental metastasis.
Journal of thrombosis and haemostasis : JTH 2009;7(9):1595-7.
2009: Federico Lussana; Sabrina Caberlon; Chiara Pagani; Pieter W Kamphuisen; Harry R Büller; Marco Cattaneo
Association of V617F Jak2 mutation with the risk of thrombosis among patients with essential thrombocythaemia or idiopathic myelofibrosis: a systematic review.
Thrombosis research 2009;124(4):409-17.
2009: Bregje Van Zaane; Erfan Nur; Alessandro Squizzato; Olaf M Dekkers; Marcel Th B Twickler; Eric Fliers; V E A Gerdes; Harry R Büller; D P M Brandjes
Hypercoagulable state in Cushing's syndrome: a systematic review.
The Journal of clinical endocrinology and metabolism 2009;94(8):2743-50.
2009: Olav R de Peuter; Wouter E M Kok; Christian Torp-Pedersen; Harry R Büller; Pieter W Kamphuisen
Systolic heart failure: a prothrombotic state.
Seminars in thrombosis and hemostasis 2009;35(5):497-504.
2009: Bregje van Zaane; Anne Q Reuwer; Harry R Büller; John J P Kastelein; V E A Gerdes; Marcel Th B Twickler
Hormones and cardiovascular disease: a shift in paradigm with clinical consequences?
Seminars in thrombosis and hemostasis 2009;35(5):478-87.
2009: Pieter W Kamphuisen; Frits R Rosendaal; Harry R Büller
Hemostatic abnormalities and arterial thrombosis.
Seminars in thrombosis and hemostasis 2009;35(5):449-50.
2009: F F van Doormaal; Alex KleinJan; Marcello Di Nisio; Harry R Büller; R Nieuwland
Cell-derived microvesicles and cancer.
The Netherlands journal of medicine 2009;67(7):266-73.
2009: J Hermanides; D M Cohn; J Hans DeVries; Pieter W Kamphuisen; R Huijgen; J C M Meijers; J B L Hoekstra; Harry R Büller
Venous thrombosis is associated with hyperglycemia at diagnosis: a case-control study.
Journal of thrombosis and haemostasis : JTH 2009;7(6):945-9.
2009: Willem M Lijfering; Jan-Leendert Brouwer; Nic J G M Veeger; Ivan Bank; Michiel Coppens; Saskia Middeldorp; Karly Hamulyák; Martin H Prins; Harry R Büller; Jan van der Meer
Selective testing for thrombophilia in patients with first venous thrombosis: results from a retrospective family cohort study on absolute thrombotic risk for currently known thrombophilic defects in 2479 relatives.
Blood 2009;113(21):5314-22.
2009: Frederiek F van Doormaal; Gary E Raskob; Bruce L Davidson; Hervé Decousus; Alexander Gallus; Anthonie W A Lensing; Franco Piovella; Martin H Prins; Harry R Büller
Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.
Thrombosis and haemostasis 2009;101(4):762-9.
2009: Iris M Wichers; Michael W T Tanck; Joost C M Meijers; Ton Lisman; Pieter H Reitsma; Frits R Rosendaal; Harry R Büller; Saskia Middeldorp
Assessment of coagulation and fibrinolysis in families with unexplained thrombophilia.
Thrombosis and haemostasis 2009;101(3):465-70.
2009: R Karami Djurabi; F A Klok; Mathilde Nijkeuter; Karin A H Kaasjager; Pieter W Kamphuisen; Mark H H Kramer; M J H A Kruip; Frank W G Leebeek; Harry R Büller; Menno V Huisman
Comparison of the clinical usefulness of two quantitative D-Dimer tests in patients with a low clinical probability of pulmonary embolism.
Thrombosis research 2009;123(5):771-4.
2009: Harry R Büller; Arina J Ten Cate-Hoek; Arno Hoes; Manuela A Joore; Karel Moons; Ruud Oudega; Martin H Prins; Henri ('Jelle') Stoffers; Diane B Toll; Eit F van der Velde; Henk C P M van Weert
Safely ruling out deep venous thrombosis in primary care.
Annals of internal medicine 2009;150(4):229-35.
2009: Anja B U Mäkelburg; Willem M Lijfering; Saskia Middeldorp; Karly Hamulyák; Nic J G M Veeger; Martin H Prins; Harry R Büller; Jan van der Meer
Low absolute risk of venous and arterial thrombosis in hyperhomocysteinaemia - a prospective family cohort study in asymptomatic subjects.
Thrombosis and haemostasis 2009;101(1):209-12.
2009: Renée A Douma; Nadine S Gibson; V E A Gerdes; Harry R Büller; Philip S Wells; Arnaud Perrier; Grégoire LE GAL
Validity and clinical utility of the simplified Wells rule for assessing clinical probability for the exclusion of pulmonary embolism.
Thrombosis and haemostasis 2009;101(1):197-200.
2009: Nienke Folkeringa; Fleurisca J Korteweg; Nic J G M Veeger; Saskia Middeldorp; Karly Hamulyak; Martin H Prins; Jan Jaap H M Erwich; Harry R Büller; Jan van der Meer
Thrombin activatable fibrinolysis inhibitor (TAFI) is not associated with fetal loss, a retrospective study.
Thrombosis research 2009;123(3):511-4.
2008: Iris M Wichers; M Haighton; Harry R Büller; Saskia Middeldorp
A retrospective analysis of patients treated for superficial vein thrombosis.
The Netherlands journal of medicine 2008;66(10):423-7.
2008: Enrico Bernardi; Giuseppe Camporese; Harry R Büller; Sergio Siragusa; Davide Imberti; Arrigo Berchio; Angelo Ghirarduzzi; Fabio Verlato; Raffaela Anastasio; Carolina Prati; Andrea Piccioli; Raffaele Pesavento; Carlo Bova; Patrizia Maltempi; Nello Zanatta; Alberto Cogo; Roberto Cappelli; Eugenio Bucherini; Stefano Cuppini; Franco Noventa; Paolo Prandoni
Serial 2-point ultrasonography plus D-dimer vs whole-leg color-coded Doppler ultrasonography for diagnosing suspected symptomatic deep vein thrombosis: a randomized controlled trial.
JAMA : the journal of the American Medical Association 2008;300(14):1653-9.
2008: Nienke Folkeringa; Michiel Coppens; Nic J G M Veeger; Victor J J Bom; Saskia Middeldorp; Karly Hamulyak; Martin H Prins; Harry R Büller; Jan van der Meer
Absolute risk of venous and arterial thromboembolism in thrombophilic families is not increased by high thrombin-activatable fibrinolysis inhibitor (TAFI) levels.
Thrombosis and haemostasis 2008;100(1):38-44.
2008: Marcel Levi; G Kees Hovingh; suzanne cannegieter; Marinus Vermeulen; Harry R Büller; Frits R Rosendaal
Bleeding in patients receiving vitamin K antagonists who would have been excluded from trials on which the indication for anticoagulation was based.
Blood 2008;111(9):4471-6.
2008: Harry R Büller; J L Halperin; H Bounameaux; M Prins
Double-blind studies are not always optimum for evaluation of a novel therapy: the case of new anticoagulants.
Journal of thrombosis and haemostasis : JTH 2008;6(2):227-9.
2008: Mathilde Nijkeuter; J M Kwakkel-van Erp; Marieke J H A Kruip; Maaike Sohne; Harry R Büller; Frank W G Leebeek; Menno V Huisman
Incidence of diagnosis of subsegmental pulmonary emboli using multidetector row and single-detector row computed tomography.
Journal of thrombosis and haemostasis : JTH 2008;6(2):384-6.
2008: Willem M Lijfering; Michiel Coppens; Nic J G M Veeger; Saskia Middeldorp; Karly Hamulyák; Martin H Prins; Harry R Büller; Jan van der Meer
Hyperhomocysteinemia is not a risk factor for venous and arterial thrombosis, and is associated with elevated factor VIII levels.
Thrombosis research 2008;123(2):244-50.
2008: F A Klok; R Karami Djurabi; Mathilde Nijkeuter; H C J Eikenboom; Frank W G Leebeek; Mark H H Kramer; Karin A H Kaasjager; Pieter W Kamphuisen; Harry R Büller; Menno V Huisman
High D-dimer level is associated with increased 15-d and 3 months mortality through a more central localization of pulmonary emboli and serious comorbidity.
British journal of haematology 2008;140(2):218-22.
2007: Saskia Kuipers; A J M Schreijer; suzanne cannegieter; Harry R Büller; Frits R Rosendaal; Saskia Middeldorp
Travel and venous thrombosis: a systematic review.
Journal of internal medicine 2007;262(6):615-34.
2007: Alessandro Squizzato; Josè Vitale; V E A Gerdes; Erica Romualdi; Harry R Büller; Walter Ageno
Recurrent deep venous thrombosis during optimal anticoagulation and overt hyperthyroidism: a case report.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2007;18(8):801-3.
2007: Ivan Bank; Marlène H W van de Poel; Michiel Coppens; Karly Hamulyák; Martin H Prins; Jan van der Meer; Nic J G M Veeger; Harry R Büller; Saskia Middeldorp
Absolute annual incidences of first events of venous thromboembolism and arterial vascular events in individuals with elevated FVIII:c. A prospective family cohort study.
Thrombosis and haemostasis 2007;98(5):1040-4.
2007: Bengt I Eriksson; Ola E Dahl; Nadia Rosencher; A A Kurth; C Niek van Dijk; Simon P Frostick; Peter Kälebo; A V Christiansen; S Hantel; Rohan Hettiarachchi; J Schnee; Harry R Büller
Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial.
Journal of thrombosis and haemostasis : JTH 2007;5(11):2178-85.
2007: Bengt I Eriksson; Ola E Dahl; Nadia Rosencher; Andreas A Kurth; C Niek van Dijk; Simon P Frostick; Martin H Prins; Rohan Hettiarachchi; Stefan Hantel; Janet Schnee; Harry R Büller
Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial.
Lancet 2007;370(9591):949-56.
2007: Saskia Kuipers; suzanne cannegieter; Saskia Middeldorp; Luc Robyn; Harry R Büller; Frits R Rosendaal
The absolute risk of venous thrombosis after air travel: a cohort study of 8,755 employees of international organisations.
PLoS medicine 2007;4(9):e290.
2007: Michiel Coppens; J A van Mourik; C M Eckmann; Harry R Büller; Saskia Middeldorp
Current practise of testing for inherited thrombophilia.
Journal of thrombosis and haemostasis : JTH 2007;5(9):1979-81.
2007: T M H Niers; Marcello Di Nisio; Clara P W Klerk; H J Baarslag; Harry R Büller; Bart J Biemond
Prevention of catheter-related venous thrombosis with nadroparin in patients receiving chemotherapy for hematologic malignancies: a randomized, placebo-controlled study.
Journal of thrombosis and haemostasis : JTH 2007;5(9):1878-82.
2007: Willem M Lijfering; Michiel Coppens; Marlène H W van de Poel; Saskia Middeldorp; Karly Hamulyák; Ivan Bank; Nic J G M Veeger; Martin H Prins; Harry R Büller; Jan van der Meer
The risk of venous and arterial thrombosis in hyperhomocysteinaemia is low and mainly depends on concomitant thrombophilic defects.
Thrombosis and haemostasis 2007;98(2):457-63.
2007: M Coppens; A J M Schreijer; F H Berger; suzanne cannegieter; Frits R Rosendaal; Harry R Büller
Mechanical prophylaxis for travellers' thrombosis: a comparison of three interventions that promote venous outflow.
Journal of thrombosis and haemostasis : JTH 2007;5(7):1556-67.
2007: Alessandro Squizzato; Erica Romualdi; Harry R Büller; V E A Gerdes
Clinical review: Thyroid dysfunction and effects on coagulation and fibrinolysis: a systematic review.
The Journal of clinical endocrinology and metabolism 2007;92(7):2415-20.
2007: Michiel Coppens; Nienke Folkeringa; M J Teune; Karly Hamulyák; Jan van der Meer; Martin H Prins; Harry R Büller; Saskia Middeldorp
Outcome of the subsequent pregnancy after a first loss in women with the factor V Leiden or prothrombin 20210A mutations.
Journal of thrombosis and haemostasis : JTH 2007;5(7):1444-8.
2007: Mathilde Nijkeuter; Hanneke Kwakkel-van Erp; Maaike Söhne; Lidwine W Tick; Marieke J H A Kruip; Eric F Ullmann; Mark H H Kramer; Harry R Büller; Martin H Prins; Frank W G Leebeek; Menno V Huisman
Clinically suspected acute recurrent pulmonary embolism: a diagnostic challenge.
Thrombosis and haemostasis 2007;97(6):944-8.
2007: Bruce L Davidson; Harry R Büller; Hervé Decousus; Alexander Gallus; Michael Gent; Franco Piovella; Martin H Prins; Gary E Raskob; A E M Segers; Anthonie W A Lensing
Effect of obesity on outcomes after fondaparinux, enoxaparin, or heparin treatment for acute venous thromboembolism in the Matisse trials.
Journal of thrombosis and haemostasis : JTH 2007;5(6):1191-4.
2007: Alessandro Squizzato; Erica Romualdi; Eliana Piantanida; V E A Gerdes; Harry R Büller; Maria Laura Tanda; Luigi Bartalena; achille venco; Walter Ageno
Subclinical hypothyroidism and deep venous thrombosis. A pilot cross-sectional study.
Thrombosis and haemostasis 2007;97(5):803-6.
2007: Igor I Tulevski; Marije ten Wolde; Dirk J van Veldhuisen; Jasper W M Mulder; Ernst E van der Wall; Harry R Büller; Barbara J M Mulder
Combined utility of brain natriuretic peptide and cardiac troponin T may improve rapid triage and risk stratification in normotensive patients with pulmonary embolism.
International journal of cardiology 2007;116(2):161-6.
2007: Bart J Biemond; Elisabeth Perzborn; Philip W Friederich; Marcel Levi; Ulf Buetehorn; Harry R Büller
Prevention and treatment of experimental thrombosis in rabbits with rivaroxaban (BAY 597939)--an oral, direct factor Xa inhibitor.
Thrombosis and haemostasis 2007;97(3):471-7.
2007: B L W Bendermacher; Joep A W Teijink; Edith M Willigendael; Marie-Louise Bartelink; Ron J G Peters; Rob A de Bie; Harry R Büller; Jelis Boiten; Machteld Langenberg; Martin H Prins
A clinical prediction model for the presence of peripheral arterial disease--the benefit of screening individuals before initiation of measurement of the ankle-brachial index: an observational study.
Vascular medicine (London, England) 2007;12(1):5-11.
2007: Mathilde Nijkeuter; Maaike Söhne; Lidwine W Tick; Pieter W Kamphuisen; Mark H H Kramer; Laurens Laterveer; Anja A van Houten; Marieke J H A Kruip; Frank W G Leebeek; Harry R Büller; Menno V Huisman
The natural course of hemodynamically stable pulmonary embolism: Clinical outcome and risk factors in a large prospective cohort study.
Chest 2007;131(2):517-23.
2007: Marcello Di Nisio; Alessandro Squizzato; Anne W S Rutjes; Harry R Büller; A H Zwinderman; Patrick Bossuyt
Diagnostic accuracy of D-dimer test for exclusion of venous thromboembolism: a systematic review.
Journal of thrombosis and haemostasis : JTH 2007;5(2):296-304.
2007: Matthijs van Wissen; Tymen T Keller; Brechje Ronkes; V E A Gerdes; Hans L Zaaijer; Eric C M van Gorp; D P M Brandjes; Marcel Levi; Harry R Büller
Influenza infection and risk of acute pulmonary embolism.
Thrombosis journal 2007;5():16.
2006: B L W Bendermacher; Joep A W Teijink; Edith M Willigendael; Marie-Louise Bartelink; Harry R Büller; Ron J G Peters; Jelis Boiten; Machteld Langenberg; Martin H Prins
Symptomatic peripheral arterial disease: the value of a validated questionnaire and a clinical decision rule.
The British journal of general practice : the journal of the Royal College of General Practitioners 2006;56(533):932-7.
2006: Nadine S Gibson; Harry R Büller
Could D-dimer provide a definitive diagnosis in patients with suspected pulmonary embolism?
Nature clinical practice. Cardiovascular medicine 2006;3(12):654-5.
2006: Tymen T Keller; Koenraad F van der Sluijs; Martijn D de Kruif; V E A Gerdes; Joost C M Meijers; Sandrine Florquin; Tom van der Poll; Eric C M van Gorp; D P M Brandjes; Harry R Büller; Marcel Levi
Effects on coagulation and fibrinolysis induced by influenza in mice with a reduced capacity to generate activated protein C and a deficiency in plasminogen activator inhibitor type 1.
Circulation research 2006;99(11):1261-9.
2006: Marcel Levi; F R Rosendaal; Harry R Büller
[Deep-vein thrombosis and pulmonary embolism due to air travel].
Nederlands tijdschrift voor geneeskunde 2006;150(45):2474-8.
2006: Marieke J H A Kruip; Maaike Söhne; Mathilde Nijkeuter; H M Kwakkel-Van Erp; Lidwine W Tick; S J M Halkes; Martin H Prins; Mark H H Kramer; Menno V Huisman; Harry R Büller; Frank W G Leebeek
A simple diagnostic strategy in hospitalized patients with clinically suspected pulmonary embolism.
Journal of internal medicine 2006;260(5):459-66.
2006: Saskia Kuipers; suzanne cannegieter; Saskia Middeldorp; Frits R Rosendaal; Harry R Büller
Use of preventive measures for air travel-related venous thrombosis in professionals who attend medical conferences.
Journal of thrombosis and haemostasis : JTH 2006;4(11):2373-6.
2006: Marnix R Hoppener; Harmen B Ettema; Christiaan P Henny; cees verheyen; Harry R Büller
Low incidence of deep vein thrombosis after knee arthroscopy without thromboprophylaxis: a prospective cohort study of 335 patients.
Acta orthopaedica 2006;77(5):767-71.
2006: M Coppens; F F van Doormaal; A J M Schreijer; Frits R Rosendaal; Harry R Büller
Intermittent mechanical compression for prevention of travellers' thrombosis.
Journal of thrombosis and haemostasis : JTH 2006;4(8):1836-8.
2006: Anne-Cornélie J M de Pont; Catherine S C Bouman; Kamran Bakhtiari; Marianne C L Schaap; Rienk Nieuwland; Augueste Sturk; Barbara A Hutten; Evert de Jonge; Margreeth B Vroom; Joost C M Meijers; Harry R Büller
Predilution versus postdilution during continuous venovenous hemofiltration: a comparison of circuit thrombogenesis.
ASAIO journal (American Society for Artificial Internal Organs : 1992) 2006;52(4):416-22.
2006: Anne-Cornélie J M de Pont; Kamran Bakhtiari; Barbara A Hutten; Evert de Jonge; George P Vlasuk; William E Rote; Marcel Levi; Harry R Büller; Joost C M Meijers
Endotoxaemia induces resistance to activated protein C in healthy humans.
British journal of haematology 2006;134(2):213-9.
2006: Andrew Miller; Ian Campbell; Tony Fennerty; Gary E Raskob; Harry R Büller
Duration of warfarin in pulmonary embolism.
Chest 2006;130(1):299; author reply 299-300.
2006: Harmen B Ettema; Marnix R Hoppener; Nic J G M Veeger; Harry R Büller; J van der Meer
Low incidence of venographically detected deep vein thrombosis after knee arthroscopy without thromboprophylaxis: a prospective cohort study.
Journal of thrombosis and haemostasis : JTH 2006;4(6):1411-3.
2006: V E A Gerdes; Vincent I H Kwa; Hugo ten Cate; D P M Brandjes; Harry R Büller; Jan Stam
Cerebral white matter lesions predict both ischemic strokes and myocardial infarctions in patients with established atherosclerotic disease.
Atherosclerosis 2006;186(1):166-72.
2006: A J M Schreijer; suzanne cannegieter; Joost C M Meijers; Saskia Middeldorp; Harry R Büller; Frits R Rosendaal
Activation of coagulation system during air travel: a crossover study.
Lancet 2006;367(9513):832-8.
2006: P L J van der Heiden; Martin H Prins; Wouter de Monyé; Marco L J van Strijen; Jan Dirk Banga; Piet E Postmus; Marije ten Wolde; Harry R Büller; D P M Brandjes; Menno V Huisman
Pulmonary embolism as a first clinical sign of occult malignancy: a prospective follow-up study.
Thrombosis and haemostasis 2006;95(3):584-5.
2006: Maaike Söhne; Marije ten Wolde; F Boomsma; J B Reitsma; James D Douketis; Harry R Büller
Brain natriuretic peptide in hemodynamically stable acute pulmonary embolism.
Journal of thrombosis and haemostasis : JTH 2006;4(3):552-6.
2006: Arne van Belle; Harry R Büller; Menno V Huisman; Peter M Huisman; Karin A H Kaasjager; Pieter W Kamphuisen; Mark H H Kramer; Marieke J H A Kruip; Johanna M Kwakkel-van Erp; Frank W G Leebeek; Mathilde Nijkeuter; Martin H Prins; Maaike Sohne; Lidwine W Tick
Effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability, D-dimer testing, and computed tomography.
JAMA : the journal of the American Medical Association 2006;295(2):172-9.
2006: Marcello Di Nisio; Anne W S Rutjes; Harry R Büller
Combined use of clinical pretest probability and D-dimer test in cancer patients with clinically suspected deep venous thrombosis.
Journal of thrombosis and haemostasis : JTH 2006;4(1):52-7.
2005: Marcello Di Nisio; Hans-Martin Otten; Andrea Piccioli; Anthonie W A Lensing; Paolo Prandoni; Harry R Büller; Martin H Prins
Decision analysis for cancer screening in idiopathic venous thromboembolism.
Journal of thrombosis and haemostasis : JTH 2005;3(11):2391-6.
2005: Marcello Di Nisio; Nick R Bijsterveld; Joost C M Meijers; Marcel Levi; Harry R Büller; Ron J G Peters
Effects of clopidogrel on the rebound hypercoagulable state after heparin discontinuation in patients with acute coronary syndromes.
Journal of the American College of Cardiology 2005;46(8):1582-3.
2005: Anne-Cornélie J M de Pont; Kamran Bakhtiari; Barbara A Hutten; Evert de Jonge; Margreeth B Vroom; Joost C M Meijers; Harry R Büller; Marcel Levi
Recombinant human activated protein C resets thrombin generation in patients with severe sepsis - a case control study.
Critical care (London, England) 2005;9(5):R490-7.
2005: Pieter H Reitsma; Jeroen F van der Heijden; Angelique P Groot; Frits R Rosendaal; Harry R Büller
A C1173T dimorphism in the VKORC1 gene determines coumarin sensitivity and bleeding risk.
PLoS medicine 2005;2(10):e312.
2005: Edith M Willigendael; Joep A W Teijink; Marie-Louise Bartelink; Machteld Langenberg; Rob J Th J Welten; Harry R Büller; Martin H Prins
Combined training of GPs and practice-assistants on peripheral arterial disease: positive effects after six months.
Family practice 2005;22(5):520-2.
2005: Roel Vink; Michiel Rienstra; Carlo J J van Dongen; Marcel Levi; Harry R Büller; Harry J G M Crijns; Isabelle C Van Gelder
Risk of thromboembolism and bleeding after general surgery in patients with atrial fibrillation.
The American journal of cardiology 2005;96(6):822-4.
2005: Marcello Di Nisio; Saskia Middeldorp; Harry R Büller
Direct thrombin inhibitors.
The New England journal of medicine 2005;353(10):1028-40.
2005: Maaike Söhne; Pieter W Kamphuisen; Patricia J W B van Mierlo; Harry R Büller
Diagnostic strategy using a modified clinical decision rule and D-dimer test to rule out pulmonary embolism in elderly in- and outpatients.
Thrombosis and haemostasis 2005;94(1):206-10.
2005: Edith M Willigendael; Joep A W Teijink; Marie-Louise Bartelink; Ron J G Peters; Harry R Büller; Martin H Prins
Smoking and the patency of lower extremity bypass grafts: a meta-analysis.
Journal of vascular surgery 2005;42(1):67-74.
2005: Marcello Di Nisio; Clara P W Klerk; J C M Meijers; Harry R Büller
The prognostic value of the D-dimer test in cancer patients treated with and without low-molecular-weight heparin.
Journal of thrombosis and haemostasis : JTH 2005;3(7):1531-3.
2005: Marcello Di Nisio; Maaike Sohne; Pieter W Kamphuisen; Harry R Büller
D-Dimer test in cancer patients with suspected acute pulmonary embolism.
Journal of thrombosis and haemostasis : JTH 2005;3(6):1239-42.
2005: Iris M Wichers; Marcello Di Nisio; Harry R Büller; Saskia Middeldorp
Treatment of superficial vein thrombosis to prevent deep vein thrombosis and pulmonary embolism: a systematic review.
Haematologica 2005;90(5):672-7.
2005: Marcel Levi; Marjolein Peters; Harry R Büller
Efficacy and safety of recombinant factor VIIa for treatment of severe bleeding: a systematic review.
Critical care medicine 2005;33(4):883-90.
2005: Clara P W Klerk; Susanne M Smorenburg; Hans-Martin Otten; Anthonie W A Lensing; Martin H Prins; Franco Piovella; Paolo Prandoni; Monique M E M Bos; Dick J Richel; Geertjan van Tienhoven; Harry R Büller
The effect of low molecular weight heparin on survival in patients with advanced malignancy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(10):2130-5.
2005: Eduard J Libourel; Ivan Bank; Nic J G M Veeger; Karly Hamulyàk; Saskia Middeldorp; Martin H Prins; Harry R Büller; Jan van der Meer
Protein S type III deficiency is no risk factor for venous and arterial thromboembolism in 168 thrombophilic families: a retrospective study.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2005;16(2):135-40.
2005: Marnix R Hoppener; Harry R Büller
New anticoagulants and thromboprophylaxis.
The British journal of surgery 2005;92(3):259-61.
2005: Alessandro Squizzato; V E A Gerdes; Harry R Büller
Effects of human cytomegalovirus infection on the coagulation system.
Thrombosis and haemostasis 2005;93(3):403-10.
2005: Angelique C M Jansen; Emily S van Aalst-Cohen; Barbara A Hutten; Harry R Büller; John J P Kastelein; Martin H Prins
Guidelines were developed for data collection from medical records for use in retrospective analyses.
Journal of clinical epidemiology 2005;58(3):269-74.
2005: Harmen B Ettema; Marnix R Hoppener; Christiaan P Henny; Harry R Büller; cees verheyen
Compliance of Dutch orthopedic departments with national guidelines on thromboprophylaxis. A survey of Dutch orthopedic thromboprohylaxis.
Acta orthopaedica 2005;76(1):99-103.
2005: Janine Dörffler-Melly; M M W Koopman; MH Prins; Harry R Büller
Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment.
Cochrane database of systematic reviews (Online) 2005;(1):CD002071.
2005: Bengt I Eriksson; Ola E Dahl; Harry R Büller; Rohan Hettiarachchi; Nadia Rosencher; M-L Bravo; Lennart Ahnfelt; Franco Piovella; Joachim Stangier; Peter Kälebo; P Reilly
A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial.
Journal of thrombosis and haemostasis : JTH 2005;3(1):103-11.
2005: Ivan Bank; Eduard J Libourel; Saskia Middeldorp; Karly Hamulyák; Elisabeth C M van Pampus; Maria M W Koopman; Martin H Prins; Jan van der Meer; Harry R Büller
Elevated levels of FVIII:C within families are associated with an increased risk for venous and arterial thrombosis.
Journal of thrombosis and haemostasis : JTH 2005;3(1):79-84.
2004: Edith M Willigendael; Joep A W Teijink; Marie-Louise Bartelink; Barthold W Kuiken; Jelis Boiten; Frans L Moll; Harry R Büller; Martin H Prins
Influence of smoking on incidence and prevalence of peripheral arterial disease.
Journal of vascular surgery 2004;40(6):1158-65.
2004: Maaike Söhne; Marije ten Wolde; Harry R Büller
Biomarkers in pulmonary embolism.
Current opinion in cardiology 2004;19(6):558-62.
2004: Saskia Middeldorp; Marlène H W van de Poel; Ivan Bank; Karly Hamulyák; Eduard J Libourel; Maria M W Koopman; Martin H Prins; Jan van der Meer; Harry R Büller
Unselected women with elevated levels of factor VIII:C or homocysteine are not at increased risk for obstetric complications.
Thrombosis and haemostasis 2004;92(4):787-90.
2004: Ivan Bank; Eduard J Libourel; Saskia Middeldorp; Elisabeth C M van Pampus; Maria M W Koopman; Karly Hamulyák; Martin H Prins; Jan van der Meer; Harry R Büller
Prothrombin 20210A mutation: a mild risk factor for venous thromboembolism but not for arterial thrombotic disease and pregnancy-related complications in a family study.
Archives of internal medicine 2004;164(17):1932-7.
2004: Edith M Willigendael; Joep A W Teijink; Marie-Louise Bartelink; Jelis Boiten; Harry R Büller; Martin H Prins
Peripheral arterial disease: the gap between common practice and the Dutch College of General Practitioners guideline.
The European journal of general practice 2004;10(3):106-7.
2004: Floortje Melis; Jan P Vandenbrouke; Harry R Büller; Louisa P Colly; Kitty W M Bloemenkamp
Estimates of risk of venous thrombosis during pregnancy and puerperium are not influenced by diagnostic suspicion and referral basis.
American journal of obstetrics and gynecology 2004;191(3):825-9.
2004: Harry R Büller; Giancarlo Agnelli; Russel D Hull; Thomas M Hyers; Martin H Prins; Gary E Raskob
Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Chest 2004;126(3 Suppl):401S-428S.
2004: Marije ten Wolde; Maaike Söhne; Elske Quak; Melvin R Mac Gillavry; Harry R Büller
Prognostic value of echocardiographically assessed right ventricular dysfunction in patients with pulmonary embolism.
Archives of internal medicine 2004;164(15):1685-9.
2004: Marnix R Hoppener; Roderik A Kraaijenhagen; Barbara A Hutten; Harry R Büller; Ron J G Peters; Marcel Levi
Beta-receptor blockade decreases elevated plasma levels of factor VIII:C in patients with deep vein thrombosis.
Journal of thrombosis and haemostasis : JTH 2004;2(8):1316-20.
2004: Albert Wiegman; Barbara A Hutten; Eric de Groot; Jessica Rodenburg; Henk D Bakker; Harry R Büller; Eric J G Sijbrands; John J P Kastelein
Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial.
JAMA : the journal of the American Medical Association 2004;292(3):331-7.
2004: M G L Leclercq; Marieke J H A Kruip; M R Mac Gillavry; Marinus van Marwijk Kooy; Harry R Büller
Observer variability in the assessment of clinical probability in patients with suspected pulmonary embolism.
Journal of thrombosis and haemostasis : JTH 2004;2(7):1204-6.
2004: Marije ten Wolde; Petronella J Hagen; Melvin R MacGillavry; I J Pollen; Albert T A Mairuhu; Maria M W Koopman; Martin H Prins; Otto S Hoekstra; D P M Brandjes; Pieter E Postmus; Harry R Büller
Non-invasive diagnostic work-up of patients with clinically suspected pulmonary embolism; results of a management study.
Journal of thrombosis and haemostasis : JTH 2004;2(7):1110-7.
2004: Jeroen F van der Heijden; B Rekké; BA Hutten; F J M van der Meer; M G H Remkes; M Vermeulen; Harry R Büller; Pieter H Reitsma
Non-fatal major bleeding during treatment with vitamin K antagonists: influence of soluble thrombomodulin and mutations in the propeptide of coagulation factor IX.
Journal of thrombosis and haemostasis : JTH 2004;2(7):1104-9.
2004: Marcel Levi; Tom van der Poll; Harry R Büller
Bidirectional relation between inflammation and coagulation.
Circulation 2004;109(22):2698-704.
2004: Harry R Büller; Bruce L Davidson; Hervé Decousus; Alexander Gallus; Michael Gent; Franco Piovella; Martin H Prins; Gary E Raskob; A E M Segers; Roger Cariou; Oscar Leeuwenkamp; Anthonie W A Lensing
Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis: a randomized trial.
Annals of internal medicine 2004;140(11):867-73.
2004: Harry R Büller
Has time come for screening for occult cancer in patients with venous thromboembolism?
Journal of thrombosis and haemostasis : JTH 2004;2(6):874-5.
2004: Edith M Willigendael; Joep A W Teijink; Marie-Louise Bartelink; Jelis Boiten; Frans L Moll; Harry R Büller; Martin H Prins
Peripheral arterial disease: public and patient awareness in The Netherlands.
European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery 2004;27(6):622-8.
2004: Marcello Di Nisio; Alessandro Squizzato; Clara P W Klerk; Dick J Richel; Harry R Büller
Antithrombotic therapy and cancer.
Current opinion in hematology 2004;11(3):187-91.
2004: V E A Gerdes; H A Kremer Hovinga; Hugo ten Cate; Melvin R MacGillavry; A Leijte; Pieter H Reitsma; D P M Brandjes; Harry R Büller
Homocysteine and markers of coagulation and endothelial cell activation.
Journal of thrombosis and haemostasis : JTH 2004;2(3):445-51.
2004: Nick R Bijsterveld; Roel Vink; Benien E van Aken; Hein Fennema; Ron J G Peters; Joost C M Meijers; Harry R Büller; Marcel Levi
Recombinant factor VIIa reverses the anticoagulant effect of the long-acting pentasaccharide idraparinux in healthy volunteers.
British journal of haematology 2004;124(5):653-8.
2004: Ivan Bank; Michael P R B Scavenius; Harry R Büller; Saskia Middeldorp
Social aspects of genetic testing for factor V Leiden mutation in healthy individuals and their importance for daily practice.
Thrombosis research 2004;113(1):7-12.
2004: Eduard J Libourel; Corine P Baljé-Volkers Degrees; Karly Hamulyàk; Martin H Prins; Saskia Middeldorp; Harry R Büller; Jan van der Meer
High factor VIII plasma levels as a risk factor for venous thrombosis: no evidence of inheritance from a family cohort study.
Haematologica 2004;89(1):118-20.
2004: Anne-Cornélie J M de Pont; Arno H M Moons; Evert de Jonge; Joost C M Meijers; George P Vlasuk; William E Rote; Harry R Büller; Tom van der Poll; Marcel Levi
Recombinant nematode anticoagulant protein c2, an inhibitor of tissue factor/factor VIIa, attenuates coagulation and the interleukin-10 response in human endotoxemia.
Journal of thrombosis and haemostasis : JTH 2004;2(1):65-70.
2003: Roel Vink; Roderik A Kraaijenhagen; Barbara A Hutten; R B A van den Brink; Bas A J M de Mol; Harry R Büller; Marcel Levi
The optimal intensity of vitamin K antagonists in patients with mechanical heart valves: a meta-analysis.
Journal of the American College of Cardiology 2003;42(12):2042-8.
2003: Harry R Büller
Factor Xa is a superior target to factor IIa for antithrombotic therapies.
Seminars in thrombosis and hemostasis 2003;29 Suppl 1():37.
2003: Roel Vink; Roderik A Kraaijenhagen; Marcel Levi; Harry R Büller
Individualized duration of oral anticoagulant therapy for deep vein thrombosis based on a decision model.
Journal of thrombosis and haemostasis : JTH 2003;1(12):2523-30.
2003: Harry R Büller; Bruce L Davidson; Hervé Decousus; Alexander Gallus; Michael Gent; Franco Piovella; Martin H Prins; Gary E Raskob; A E M van den Berg-Segers; R Cariou; Oscar Leeuwenkamp; Anthonie W A Lensing
Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism.
The New England journal of medicine 2003;349(18):1695-702.
2003: Job Harenberg; Hanno Riess; Harry R Büller; Joachim Brom; Gottfried Weidinger; Menno V Huisman
Comparison of six-month outcome of patients initially treated for acute deep vein thrombosis with a low molecular weight heparin Certoparin at a fixed, body-weight-independent dosage or unfractionated heparin.
Haematologica 2003;88(10):1157-62.
2003: Maria M W Koopman; Harry R Büller
Short- and long-acting synthetic pentasaccharides.
Journal of internal medicine 2003;254(4):335-42.
2003: Harmen B Ettema; Marnix R Hoppener; Harry R Büller; Ch P Henny; cees verheyen
[Thrombosis prophylaxis in orthopaedic surgery: considerations and uncertainties].
Nederlands tijdschrift voor geneeskunde 2003;147(38):1842-7.
2003: Clara P W Klerk; Susanne M Smorenburg; Harry R Büller
Thrombosis prophylaxis in patient populations with a central venous catheter: a systematic review.
Archives of internal medicine 2003;163(16):1913-21.
2003: I Bank; Melvin R Mac Gillavry; D P M Brandjes; Harry R Büller
Does the location of deep venous thrombosis of the leg determine the risk of the post-thrombotic syndrome?
Journal of thrombosis and haemostasis : JTH 2003;1(9):2058-9.
2003: Harry R Büller; Martin H Prins
Secondary prophylaxis with warfarin for venous thromboembolism.
The New England journal of medicine 2003;349(7):702-4.
2003: Nick R Bijsterveld; Arno H M Moons; Joost C M Meijers; Marcel Levi; Harry R Büller; Ron J G Peters
The impact on coagulation of an intravenous loading dose in addition to a subcutaneous regimen of low-molecular-weight heparin in the initial treatment of acute coronary syndromes.
Journal of the American College of Cardiology 2003;42(3):424-7.
2003: Martin H Prins; Harry R Büller
When do we need what evidence?
Journal of clinical epidemiology 2003;56(8):709-10.
2003: Carlo J J van Dongen; Martin H Prins; Harry R Büller
Low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism.
The New England journal of medicine 2003;349(4):398-400; author reply 398-400.
2003: Ivan Bank; Lidwine W Tick; Barbara A Hutten; Mark H H Kramer; Saskia Middeldorp; Harry R Büller
Acquired and inherited thrombophilic factors and the risk for residual venous thrombosis.
Pathophysiology of haemostasis and thrombosis 2003;33(4):192-6.
2003: Mirjam Locadia; Mirjam A G Sprangers; Hanneke C J M de Haes; Harry R Büller; Martin H Prins
Quality of life and the duration of treatment with vitamin K antagonists in patients with deep venous thrombosis.
Thrombosis and haemostasis 2003;90(1):101-7.
2003: Anne-Cornélie J M de Pont; Catherine S C Bouman; Evert de Jonge; Margreeth B Vroom; Harry R Büller; Marcel Levi
Treatment with recombinant human activated protein C obviates additional anticoagulation during continuous venovenous hemofiltration in patients with severe sepsis.
Intensive care medicine 2003;29(7):1205.
2003: Arno H M Moons; Ron J G Peters; Nick R Bijsterveld; Jan J Piek; Martin H Prins; George P Vlasuk; William E Rote; Harry R Büller
Recombinant nematode anticoagulant protein c2, an inhibitor of the tissue factor/factor VIIa complex, in patients undergoing elective coronary angioplasty.
Journal of the American College of Cardiology 2003;41(12):2147-53.
2003: Marieke J H A Kruip; Monique G L Leclercq; Cees van der Heul; Martin H Prins; Harry R Büller
Diagnostic strategies for excluding pulmonary embolism in clinical outcome studies. A systematic review.
Annals of internal medicine 2003;138(12):941-51.
2003: Carlo J J van Dongen; Roel Vink; Barbara A Hutten; Harry R Büller; Martin H Prins
The incidence of recurrent venous thromboembolism after treatment with vitamin K antagonists in relation to time since first event: a meta-analysis.
Archives of internal medicine 2003;163(11):1285-93.
2003: Marije ten Wolde; Igor I Tulevski; J W M Mulder; Maaike Söhne; F Boomsma; Barbara J M Mulder; Harry R Büller
Brain natriuretic peptide as a predictor of adverse outcome in patients with pulmonary embolism.
Circulation 2003;107(16):2082-4.
2003: Ivan Bank; Eduard J Libourel; Saskia Middeldorp; Jan van der Meer; Harry R Büller
High rate of skin complications due to low-molecular-weight heparins in pregnant women.
Journal of thrombosis and haemostasis : JTH 2003;1(4):859-61.
2003: Marije ten Wolde; Roderik A Kraaijenhagen; Jan Schiereck; Petronella J Hagen; Joost J Mathijssen; Melvin R Mac Gillavry; Maria M W Koopman; Harry R Büller
Travel and the risk of symptomatic venous thromboembolism.
Thrombosis and haemostasis 2003;89(3):499-505.
2003: V E A Gerdes; Roel P Verkooyen; Vincent I H Kwa; Eric de Groot; Eric C M van Gorp; Hugo ten Cate; D P M Brandjes; Harry R Büller
Chlamydial LPS antibodies, intima-media thickness and ischemic events in patients with established atherosclerosis.
Atherosclerosis 2003;167(1):65-71.
2003: Guido Tans; Bonno N Bouma; Harry R Büller; Jan Rosing
Changes of hemostatic variables during oral contraceptive use.
Seminars in vascular medicine 2003;3(1):61-8.
2003: Philip W Friederich; Christiaan P Henny; Embert Messelink; Mark G Geerdink; Tymen Keller; Karl-Heinz Kurth; Harry R Büller; Marcel Levi
Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: a double-blind placebo-controlled randomised trial.
Lancet 2003;361(9353):201-5.
2003: Roderik A Kraaijenhagen; J Wallis; Maria M W Koopman; MR de Groot; Franco Piovella; Paolo Prandoni; Harry R Büller
Can causes of false-normal D-dimer test [SimpliRED] results be identified?
Thrombosis research 2003;111(3):155-8.
2003: Janine Dörffler-Melly; Harry R Büller; M M W Koopman; MH Prins
Antithrombotic agents for preventing thrombosis after infrainguinal arterial bypass surgery.
Cochrane database of systematic reviews (Online) 2003;(4):CD000536.
2003: Janine Dörffler-Melly; M M W Koopman; D J Adam; Harry R Büller; MH Prins
Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery.
Cochrane database of systematic reviews (Online) 2003;(3):CD000535.
2003: D Haverkamp; Barbara A Hutten; Harry R Büller; Alexander Gallus; Anthonie W A Lensing; Martin H Prins
The use of specific antidotes as a response to bleeding complications during anticoagulant therapy for venous thromboembolism.
Journal of thrombosis and haemostasis : JTH 2003;1(1):69-73.
2003: Monique G L Leclercq; Johan G Lutisan; Marinus van Marwijk Kooy; Bart F Kuipers; Ad H J Oostdijk; Jef J C M van der Leur; Harry R Büller
Ruling out clinically suspected pulmonary embolism by assessment of clinical probability and D-dimer levels: a management study.
Thrombosis and haemostasis 2003;89(1):97-103.
2002: Nick R Bijsterveld; Arno H M Moons; S Matthijs Boekholdt; Benien E van Aken; Hein Fennema; Ron J G Peters; Joost C M Meijers; Harry R Büller; Marcel Levi
Ability of recombinant factor VIIa to reverse the anticoagulant effect of the pentasaccharide fondaparinux in healthy volunteers.
Circulation 2002;106(20):2550-4.
2002: Harry R Büller
[Diagnostic workup for indicating the presence of pulmonary embolism: still not optimal].
Nederlands tijdschrift voor geneeskunde 2002;146(44):2073-4.
2002: C Heleen van Ommen; Jaap Ottenkamp; Jan Lam; Machteld Brennickmeier; Hugo S A Heijmans; Harry R Büller; Marjolein Peters
The risk of postthrombotic syndrome in children with congenital heart disease.
The Journal of pediatrics 2002;141(4):582-6.
2002: Eduard J Libourel; Ivan Bank; Johan R Meinardi; Corinne P Baljé -Volkers; Karly Hamulyak; Saskia Middeldorp; Maria M W Koopman; Elisabeth C M van Pampus; Martin H Prins; Harry R Büller; Jan van der Meer
Co-segregation of thrombophilic disorders in factor V Leiden carriers; the contributions of factor VIII, factor XI, thrombin activatable fibrinolysis inhibitor and lipoprotein(a) to the absolute risk of venous thromboembolism.
Haematologica 2002;87(10):1068-73.
2002: Arno H M Moons; Ron J G Peters; Hugo ten Cate; Kenneth A Bauer; George P Vlasuk; Harry R Büller; Marcel Levi
Recombinant nematode anticoagulant protein c2, a novel inhibitor of tissue factor-factor VIIa activity, abrogates endotoxin-induced coagulation in chimpanzees.
Thrombosis and haemostasis 2002;88(4):627-31.
2002: Wouter de Monyé; Bernd-Jan Sanson; Harry R Büller; Peter M T Pattynama; Menno V Huisman
The performance of two rapid quantitative D-dimer assays in 287 patients with clinically suspected pulmonary embolism.
Thrombosis research 2002;107(6):283-6.
2002: Marije ten Wolde; Roderik A Kraaijenhagen; Martin H Prins; Harry R Büller
The clinical usefulness of D-dimer testing in cancer patients with suspected deep venous thrombosis.
Archives of internal medicine 2002;162(16):1880-4.
2002: Marieke J H A Kruip; Marjan J Slob; Joost H E M Schijen; Cees van der Heul; Harry R Büller
Use of a clinical decision rule in combination with D-dimer concentration in diagnostic workup of patients with suspected pulmonary embolism: a prospective management study.
Archives of internal medicine 2002;162(14):1631-5.
2002: Niklaus Strebel; Martin Prins; Giancarlo Agnelli; Harry R Büller
Preoperative or postoperative start of prophylaxis for venous thromboembolism with low-molecular-weight heparin in elective hip surgery?
Archives of internal medicine 2002;162(13):1451-6.
2002: V E A Gerdes; Hugo ten Cate; Eric de Groot; Vincent I H Kwa; Martin H Prins; Pieter H Reitsma; Harry R Büller; D P M Brandjes
Arterial wall thickness and the risk of recurrent ischemic events in carriers of the prothrombin G20210A mutation with clinical manifestations of atherosclerosis.
Atherosclerosis 2002;163(1):135-40.
2002: Alexander G G Turpie; Harry R Büller
Benefit of selective factor inhibition.
Seminars in thrombosis and hemostasis 2002;28 Suppl 2():49-50.
2002: Harry R Büller
Treatment of symptomatic venous thromboembolism: improving outcomes.
Seminars in thrombosis and hemostasis 2002;28 Suppl 2():41-8.
2002: Jeroen F van der Heijden; M G H Remkes; Harry R Büller; M Vermeulen
Treatment with vitamin K antagonists: frequency of indications and appropriateness of continuation.
Pathophysiology of haemostasis and thrombosis 2002;32(3):111-4.
2002: Roderik A Kraaijenhagen; Franco Piovella; Enrico Bernardi; Fabio Verlato; Erik A M Beckers; Maria M W Koopman; Marisa Barone; Giuseppe Camporese; Bert Jan Potter Van Loon; Martin H Prins; Paolo Prandoni; Harry R Büller
Simplification of the diagnostic management of suspected deep vein thrombosis.
Archives of internal medicine 2002;162(8):907-11.
2002: Janine Dörffler-Melly; Evert de Jonge; Anne-Corneliede Pont; Joost Meijers; Margreet B Vroom; Harry R Büller; Marcel Levi
Bioavailability of subcutaneous low-molecular-weight heparin to patients on vasopressors.
Lancet 2002;359(9309):849-50.
2002: Nick R Bijsterveld; Arno H M Moons; Joost C M Meijers; Jan G P Tijssen; Harry R Büller; Marcel Levi; Ron J G Peters
Rebound thrombin generation after heparin therapy in unstable angina. A randomized comparison between unfractionated and low-molecular-weight heparin.
Journal of the American College of Cardiology 2002;39(5):811-7.
2002: J M M B Otten; Susanne M Smorenburg; M A de Meij; C A van der Schoor; D P M Brandjes; Harry R Büller
Screening for cancer in patients with idiopathic venous thromboembolism: the clinical practice.
Pathophysiology of haemostasis and thrombosis 2002;32(2):76-9.
2002: Johan R Meinardi; Saskia Middeldorp; Pieter J de Kam; Maria M W Koopman; Elisabeth C M van Pampus; Karly Hamulyák; Martin H Prins; Harry R Büller; Jan van der Meer
The incidence of recurrent venous thromboembolism in carriers of factor V Leiden is related to concomitant thrombophilic disorders.
British journal of haematology 2002;116(3):625-31.
2002: Saskia Middeldorp; Jan van der Meer; Karly Hamulyák; Harry R Büller
A rebuttal: Counseling pregnant women with factor V Leiden homozygosity: use absolute instead of relative risks.
Thrombosis and haemostasis 2002;87(2):360-1; author reply 361.
2002: Wouter de Monyé; Bernd-Jan Sanson; Melvin R Mac Gillavry; Peter M T Pattynama; Harry R Büller; Annette A van den Berg-Huysmans; Menno V Huisman
Embolus location affects the sensitivity of a rapid quantitative D-dimer assay in the diagnosis of pulmonary embolism.
American journal of respiratory and critical care medicine 2002;165(3):345-8.
2002: Jeroen F van der Heijden; BA Hutten; Harry R Büller; Martin H Prins
Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism.
Cochrane database of systematic reviews (Online) 2002;(1):CD002001.
2001: S Matthijs Boekholdt; Nick R Bijsterveld; Arno H M Moons; Marcel Levi; Harry R Büller; Ron J G Peters
Genetic variation in coagulation and fibrinolytic proteins and their relation with acute myocardial infarction: a systematic review.
Circulation 2001;104(25):3063-8.
2001: Susanne M Smorenburg; Roel Vink; Hans-Martin Otten; F Swaneveld; Harry R Büller
The effects of vitamin K-antagonists on survival of patients with malignancy: a systematic analysis.
Thrombosis and haemostasis 2001;86(6):1586-7.
2001: Johan R Meinardi; Saskia Middeldorp; Pieter J de Kam; Maria M W Koopman; Elisabeth C M van Pampus; Karly Hamulyák; Martin H Prins; Harry R Büller; Jan van der Meer
Risk of venous thromboembolism in carriers of factor V Leiden with a concomitant inherited thrombophilic defect: a retrospective analysis.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2001;12(8):713-20.
2001: Igor I Tulevski; Alexander Hirsch; B J Sanson; Hans Romkes; Ernst E van der Wall; Dirk J van Veldhuisen; Harry R Büller; Barbara J M Mulder
Increased brain natriuretic peptide as a marker for right ventricular dysfunction in acute pulmonary embolism.
Thrombosis and haemostasis 2001;86(5):1193-6.
2001: Evert de Jonge; Marcel Levi; Harry R Büller; F Berends; Jozef Kesecioglu
Decreased circulating levels of von Willebrand factor after intravenous administration of a rapidly degradable hydroxyethyl starch (HES 200/0.5/6) in healthy human subjects.
Intensive care medicine 2001;27(11):1825-9.
2001: C Heleen van Ommen; H Heijboer; Harry R Büller; R A Hirasing; H S Heijmans; Marjolein Peters
Venous thromboembolism in childhood: a prospective two-year registry in The Netherlands.
The Journal of pediatrics 2001;139(5):676-81.
2001: Saskia Middeldorp; Johan R Meinardi; Maria M W Koopman; Elisabeth C M van Pampus; Karly Hamulyák; Jan van der Meer; Martin H Prins; Harry R Büller
A prospective study of asymptomatic carriers of the factor V Leiden mutation to determine the incidence of venous thromboembolism.
Annals of internal medicine 2001;135(5):322-7.
2001: Melvin R Mac Gillavry; Harry R Büller; D P M Brandjes
The usefulness of compression ultrasonography of the lower limbs in patients with a clinical suspicion of pulmonary embolism.
Thrombosis and haemostasis 2001;86(2):726.
2001: Melvin R Mac Gillavry; JG Lijmer; Bernd-Jan Sanson; Harry R Büller; D P M Brandjes
Diagnostic accuracy of triage tests to exclude pulmonary embolism.
Thrombosis and haemostasis 2001;85(6):995-8.
2001: Philip W Friederich; Marcel Levi; Kenneth A Bauer; George P Vlasuk; William E Rote; D Breederveld; T Keller; M Spataro; Samad Barzegar; Harry R Büller
Ability of recombinant factor VIIa to generate thrombin during inhibition of tissue factor in human subjects.
Circulation 2001;103(21):2555-9.
2001: Saskia Middeldorp; Eduard J Libourel; Karly Hamulyák; Jan van der Meer; Harry R Büller
The risk of pregnancy-related venous thromboembolism in women who are homozygous for factor V Leiden.
British journal of haematology 2001;113(2):553-5.
2001: Ieneke J C Hartmann; Martin H Prins; Harry R Büller; Jan-Dirk Banga
Acute pulmonary embolism: impact of selection bias in prospective diagnostic studies. ANTELOPE Study Group. Advances in New Technologies Evaluating the Localization of Pulmonary Embolism.
Thrombosis and haemostasis 2001;85(4):604-8.
2001: Lloyd Fisher; Michael Gent; Harry R Büller
Active-control trials: how would a new agent compare with placebo? A method illustrated with clopidogrel, aspirin, and placebo.
American heart journal 2001;141(1):26-32.
2000: Melvin R Mac Gillavry; Bernd-Jan Sanson; Harry R Büller; D P M Brandjes
Compression ultrasonography of the leg veins in patients with clinically suspected pulmonary embolism: is a more extensive assessment of compressibility useful?
Thrombosis and haemostasis 2000;84(6):973-6.
2000: Philip W Friederich; Tymen T Keller; Bart J Biemond; Ron J G Peters; W Hornberger; Harry R Büller; Marcel Levi
Successful attenuation of venous thrombus growth in rabbits after the administration of a novel oral thrombin inhibitor.
Thrombosis and haemostasis 2000;84(5):858-64.
2000: Saskia Middeldorp; Harry R Büller
How to decide on the optimal duration of anticoagulatn therapy in carriers of the factor V Leiden mutation.
Thrombosis and haemostasis 2000;84(5):740-1.
2000: Roderik A Kraaijenhagen; D Haverkamp; M M Koopman; Paolo Prandoni; Franco Piovella; Harry R Büller
Travel and risk of venous thrombosis.
Lancet 2000;356(9240):1492-3.
2000: Jeroen F van der Heijden; Martin H Prins; Harry R Büller
For the initial treatment of venous thromboembolism: are all low-molecular-weight heparin compounds the same?
Thrombosis research 2000;100(2):V121-30.
2000: MR de Groot; Ad H J Oostdijk; A H Engelage; Marinus van Marwijk Kooy; Harry R Büller
Changes in perfusion scintigraphy in the first days of heparin therapy in patients with acute pulmonary embolism.
European journal of nuclear medicine 2000;27(10):1481-6.
2000: Melvin R Mac Gillavry; Bernd-Jan Sanson; Wouter de Monyé; JG Lijmer; Menno V Huisman; Harry R Büller; W Nieuwenhuizen; D P M Brandjes
Use of a new monoclonal antibody-based enzyme immunoassay for soluble fibrin to exclude pulmonary embolism. ANTELOPE-Study Group.
Thrombosis and haemostasis 2000;84(3):474-7.
2000: Barbara A Hutten; Martin H Prins; Michael Gent; J Ginsberg; Jan G P Tijssen; Harry R Büller
Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio: a retrospective analysis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(17):3078-83.
2000: ME Cromheecke; Marcel Levi; L P Colly; B J de Mol; Martin H Prins; B A Hutten; R Mak; K C Keyzers; Harry R Büller
Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison.
Lancet 2000;356(9224):97-102.
2000: Guido Tans; Joyce Curvers; S Middeldorp; M Christella L G D Thomassen; Joost C M Meijers; Martin H Prins; Bonno N Bouma; Harry R Büller; Jan Rosing
A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways.
Thrombosis and haemostasis 2000;84(1):15-21.
2000: Joost C M Meijers; Saskia Middeldorp; Winnie L Tekelenburg; Abraham E van den Ende; Guido Tans; Martin H Prins; Jan Rosing; Harry R Büller; Bonno N Bouma
Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives.
Thrombosis and haemostasis 2000;84(1):9-14.
2000: Saskia Middeldorp; Joost C M Meijers; Abraham E van den Ende; A van Enk; Bonno N Bouma; Guido Tans; Jan Rosing; Martin H Prins; Harry R Büller
Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: a cross-over study.
Thrombosis and haemostasis 2000;84(1):4-8.
2000: Melvin R Mac Gillavry; Wouter de Monyé; JG Lijmer; W Nieuwenhuizen; Harry R Büller; Menno V Huisman; D P M Brandjes
Clinical evaluation of a monoclonal antibody-based enzyme immunoassay for fibrin degradation products in patients with clinically suspected pulmonary embolism. ANTELOPE-Study Group.
Thrombosis and haemostasis 2000;83(6):892-5.
2000: Philip W Friederich; M G Geerdink; M Spataro; Embert Messelink; Christiaan P Henny; Harry R Büller; Marcel Levi
The effect of the administration of recombinant activated factor VII (NovoSeven) on perioperative blood loss in patients undergoing transabdominal retropubic prostatectomy: the PROSE study.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2000;11 Suppl 1():S129-32.
2000: Bruno Girolami; Enrico Bernardi; Martin H Prins; JW Ten Cate; Paolo Prandoni; Paolo Simioni; Giuseppe Maria Andreozzi; Antonio Girolami; Harry R Büller
Antiplatelet therapy and other interventions after revascularisation procedures in patients with peripheral arterial disease: a meta-analysis.
European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery 2000;19(4):370-80.
2000: N R Bijsterveld; Saskia Middeldorp; F Berends; Harry R Büller
Monitoring therapy with vitamin K antagonists in patients with lupus anticoagulant: effect on different tests for INR determination.
Journal of thrombosis and thrombolysis 2000;9(3):263-9.
2000: MR de Groot; F Turkstra; Marinus van Marwijk Kooy; Ad H J Oostdijk; Edwin J R Van Beek; Harry R Büller
Value of chest X-ray combined with perfusion scan versus ventilation/perfusion scan in acute pulmonary embolism.
Thrombosis and haemostasis 2000;83(3):412-5.
2000: Bernd-Jan Sanson; JG Lijmer; Melvin R Mac Gillavry; F Turkstra; Martin H Prins; Harry R Büller
Comparison of a clinical probability estimate and two clinical models in patients with suspected pulmonary embolism. ANTELOPE-Study Group.
Thrombosis and haemostasis 2000;83(2):199-203.
2000: Jeroen F van der Heijden; Martin H Prins; Harry R Büller
Low-molecular-weight heparins: are they interchangeable?
Haemostasis 2000;30 Suppl 2():148-57; discussion 146-7.
2000: MR de Groot; T L Njo; Marinus van Marwijk Kooy; Harry R Büller
Abrupt versus gradual withdrawal of vitamin K antagonist treatment in patients with venous thromboembolic disease: assessment of hypercoagulability and clinical outcome.
Clinical laboratory 2000;46(11-12):575-81.
2000: BA Hutten; Harry R Büller; Martin H Prins
Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism.
Cochrane database of systematic reviews (Online) 2000;(4):CD002001.
2000: Roderik A Kraaijenhagen; P S in't Anker; Maria M W Koopman; Pieter H Reitsma; Martin H Prins; Abraham E van den Ende; Harry R Büller
High plasma concentration of factor VIIIc is a major risk factor for venous thromboembolism.
Thrombosis and haemostasis 2000;83(1):5-9.
1999: Jan Rosing; S Middeldorp; Joyce Curvers; M Christella; L G D Thomassen; Gerry A F Nicolaes; Joost C M Meijers; Bonno N Bouma; Harry R Büller; Martin H Prins; Guido Tans
Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study.
Lancet 1999;354(9195):2036-40.
1999: Marcel Levi; ME Cromheecke; Evert de Jonge; Martin H Prins; B J de Mol; E Briët; Harry R Büller
Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints.
Lancet 1999;354(9194):1940-7.
1999: Susanne M Smorenburg; RJ Hettiarachchi; Roel Vink; Harry R Büller
The effects of unfractionated heparin on survival in patients with malignancy--a systematic review.
Thrombosis and haemostasis 1999;82(6):1600-4.
1999: MR de Groot; Marinus van Marwijk Kooy; J G Pouwels; A H Engelage; B F Kuipers; Harry R Büller
The use of a rapid D-dimer blood test in the diagnostic work-up for pulmonary embolism: a management study.
Thrombosis and haemostasis 1999;82(6):1588-92.
1999: Bernd-Jan Sanson; Paolo Simioni; Daniela Tormene; M Moia; Philip W Friederich; Menno V Huisman; Paolo Prandoni; A Bura; L Rejto; P Wells; P M Mannucci; Antonio Girolami; Harry R Büller; Martin H Prins
The incidence of venous thromboembolism in asymptomatic carriers of a deficiency of antithrombin, protein C, or protein S: a prospective cohort study.
Blood 1999;94(11):3702-6.
1999: Bernd-Jan Sanson; A J Meinders; Roderik A Kraaijenhagen; Edwin J R Van Beek; Harry R Büller
Requirements for appropriate evaluation of diagnostic tests in suspected pulmonary embolism.
Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace / Fondazione clinica del lavoro, IRCCS [and] Istituto di clinica tisiologica e malattie apparato respiratorio, Università di Napoli, Secondo ateneo 1999;54(5):417-21.
1999: Marieke J H A Kruip; M J Slob; Harry R Büller; Cees van der Heul
A prospective clinical study on the feasibility and safety of a combined noninvasive/pulmonary angiography strategy in patients with suspected pulmonary embolism: an interim analysis.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 1999;5(4):222-5.
1999: Barbara A Hutten; Martin H Prins; WK Redekop; Jan G P Tijssen; Siem H Heisterkamp; Harry R Büller
Comparison of three methods to assess therapeutic quality control of treatment with vitamin K antagonists.
Thrombosis and haemostasis 1999;82(4):1260-3.
1999: ME Wittekoek; Eric de Groot; Martin H Prins; Mieke D Trip; Harry R Büller; John J P Kastelein
Differences in intima-media thickness in the carotid and femoral arteries in familial hypercholesterolemic heterozygotes with and without clinical manifestations of cardiovascular disease.
Atherosclerosis 1999;146(2):271-9.
1999: Nick R Bijsterveld; RJ Hettiarachchi; R Peters; Martin H Prins; Marcel Levi; Harry R Büller
Low-molecular weight heparins in venous and arterial thrombotic disease.
Thrombosis and haemostasis 1999;82 Suppl 1():139-47.
1999: J R Mainardi; P M Pelsma; H Koning; Jan van der Meer; Saskia Middeldorp; Harry R Büller; Karly Hamulyák
Double-homozygosity for factor V Leiden and the prothrombin gene G20210A variant in a young patient with idiopathic venous thrombosis.
Blood 1999;94(5):1828-9.
1999: RJ Hettiarachchi; Susanne M Smorenburg; J Ginsberg; M Levine; Martin H Prins; Harry R Büller
Do heparins do more than just treat thrombosis? The influence of heparins on cancer spread.
Thrombosis and haemostasis 1999;82(2):947-52.
1999: Martin H Prins; Barbara A Hutten; Maria M W Koopman; Harry R Büller
Long-term treatment of venous thromboembolic disease.
Thrombosis and haemostasis 1999;82(2):892-8.
1999: J W ten Cate; Harry R Büller
[Clinical research and pharmaceutical industry. A relationship with advantages and disadvantages].
Nederlands tijdschrift voor geneeskunde 1999;143(30):1572-6.
1999: Susanne M Smorenburg; Roel Vink; M te Lintelo; W Tigchelaar; A Maas; Harry R Büller; Cornelis J F Van Noorden
In vivo treatment of rats with unfractionated heparin (UFH) or low molecular weight heparin (LMWH) does not affect experimentally induced colon carcinoma metastasis.
Clinical & experimental metastasis 1999;17(5):451-6.
1999: Marielle van Pampus; Maria M W Koopman; Hans Wolf; Harry R Büller; Martin H Prins; Abraham E van den Ende
Lipoprotein(a) concentrations in women with a history of severe preeclampsia--a case control study.
Thrombosis and haemostasis 1999;82(1):10-3.
1999: Bernd-Jan Sanson; A J Meinders; Roderik A Kraaijenhagen; Edwin J R Van Beek; Harry R Büller
Requirements for appropriate evaluation of diagnostic tests in suspected pulmonary embolism.
Haematologica 1999;84 Suppl EHA-4():78-81.
1999: Johan R Meinardi; Saskia Middeldorp; Pieter J de Kam; Maria M W Koopman; Elisabeth C M van Pampus; Karly Hamulyák; Martin H Prins; Harry R Büller; Jan van der Meer
Increased risk for fetal loss in carriers of the factor V Leiden mutation.
Annals of internal medicine 1999;130(9):736-9.
1999: Bruno Girolami; Enrico Bernardi; Martin H Prins; JW Ten Cate; Paolo Prandoni; R Hettiarachchi; E Marras; Piero M Stefani; Antonio Girolami; Harry R Büller
Antithrombotic drugs in the primary medical management of intermittent claudication: a meta-analysis.
Thrombosis and haemostasis 1999;81(5):715-22.
1999: Bernd-Jan Sanson; Anthonie W A Lensing; Martin H Prins; J S Ginsberg; Z S Barkagan; E Lavenne-Pardonge; B Brenner; M Dulitzky; J D Nielsen; Z Boda; S Turi; Melvin R Mac Gillavry; Karly Hamulyák; I M Theunissen; B J Hunt; Harry R Büller
Safety of low-molecular-weight heparin in pregnancy: a systematic review.
Thrombosis and haemostasis 1999;81(5):668-72.
1999: PM Kuijer; Barbara A Hutten; Martin H Prins; Harry R Büller
Prediction of the risk of bleeding during anticoagulant treatment for venous thromboembolism.
Archives of internal medicine 1999;159(5):457-60.
1999: F Turkstra; R Karemaker; PM Kuijer; Martin H Prins; Harry R Büller
Is the prevalence of the factor V Leiden mutation in patients with pulmonary embolism and deep vein thrombosis really different?
Thrombosis and haemostasis 1999;81(3):345-8.
1999: Bruno Girolami; Enrico Bernardi; Martin H Prins; JW Ten Cate; R Hettiarachchi; Paolo Prandoni; Antonio Girolami; Harry R Büller
Treatment of intermittent claudication with physical training, smoking cessation, pentoxifylline, or nafronyl: a meta-analysis.
Archives of internal medicine 1999;159(4):337-45.
1999: Anthonie W A Lensing; Paolo Prandoni; Martin H Prins; Harry R Büller
Deep-vein thrombosis.
Lancet 1999;353(9151):479-85.
1999: Paolo Simioni; Bernd-Jan Sanson; Paolo Prandoni; Daniela Tormene; Philip W Friederich; Bruno Girolami; Sabrina Gavasso; Menno V Huisman; Harry R Büller; J Wouter ten Cate; Antonio Girolami; Martin H Prins
Incidence of venous thromboembolism in families with inherited thrombophilia.
Thrombosis and haemostasis 1999;81(2):198-202.
1998: Roderik A Kraaijenhagen; Anthonie W A Lensing; J W Wallis; Edwin J R Van Beek; JW ten Cate; Harry R Büller
Diagnostic management of venous thromboembolism.
Baillière's clinical haematology 1998;11(3):541-86.
1998: Steven A J Chamuleau; Robbert J De Winter; Marcel Levi; R Adams; Harry R Büller; Martin H Prins; Kong I Lie; Ron J G Peters
Low molecular weight heparin as an adjunct to thrombolysis for acute myocardial infarction: the FATIMA study. Fraxiparin Anticoagulant Therapy in Myocardial Infarction Study Amsterdam (FATIMA) Study Group.
Heart (British Cardiac Society) 1998;80(1):35-9.
1998: MR de Groot; Harry R Büller; J W ten Cate; Marinus van Marwijk Kooy
Use of a heparin nomogram for treatment of patients with venous thromboembolism in a community hospital.
Thrombosis and haemostasis 1998;80(1):70-3.
1998: RJ Hettiarachchi; J Lok; Martin H Prins; Harry R Büller; Paolo Prandoni
Undiagnosed malignancy in patients with deep vein thrombosis: incidence, risk indicators, and diagnosis.
Cancer 1998;83(1):180-5.
1998: AG van den Belt; Patrick Bossuyt; Martin H Prins; A S Gallus; Harry R Büller
Replacing inpatient care by outpatient care in the treatment of deep venous thrombosis--an economic evaluation. TASMAN Study Group.
Thrombosis and haemostasis 1998;79(2):259-63.
1998: Harry R Büller
Outpatient therapy with low-molecular-weight heparins: new perspectives for treatment of deep vein thrombosis.
Haemostasis 1998;28 Suppl 3():91-4.
1998: Harry R Büller; Roderik A Kraaijenhagen; Maria M W Koopman
Early discharge strategies following venous thrombosis.
Vascular medicine (London, England) 1998;3(1):47-50.
1998: F Turkstra; Edwin J R Van Beek; Harry R Büller
Observer and biological variation of a rapid whole blood D-dimer test.
Thrombosis and haemostasis 1998;79(1):91-3.
1998: Saskia Middeldorp; CM Henkens; Maria M W Koopman; Elisabeth C M van Pampus; Karly Hamulyák; Jan van der Meer; Martin H Prins; Harry R Büller
The incidence of venous thromboembolism in family members of patients with factor V Leiden mutation and venous thrombosis.
Annals of internal medicine 1998;128(1):15-20.
1997: Edwin J R Van Beek; PM Kuijer; Harry R Büller; D P M Brandjes; Patrick Bossuyt; JW ten Cate
The clinical course of patients with suspected pulmonary embolism.
Archives of internal medicine 1997;157(22):2593-8.
1997: AG van den Belt; Bernd-Jan Sanson; Paolo Simioni; Paolo Prandoni; Harry R Büller; Antonio Girolami; Martin H Prins
Recurrence of venous thromboembolism in patients with familial thrombophilia.
Archives of internal medicine 1997;157(19):2227-32.
1997: Y P Graafsma; Martin H Prins; Anthonie W A Lensing; R J de Haan; Menno V Huisman; Harry R Büller
Bleeding classification in clinical trials: observer variability and clinical relevance.
Thrombosis and haemostasis 1997;78(4):1189-92.
1997: Bart J Biemond; Philip W Friederich; Marlys L Koschinsky; Marcel Levi; Waheed Sangrar; J Xia; Harry R Büller; JW ten Cate
Apolipoprotein(a) attenuates endogenous fibrinolysis in the rabbit jugular vein thrombosis model in vivo.
Circulation 1997;96(5):1612-5.
1997: F Turkstra; Maria M W Koopman; Harry R Büller
The treatment of deep vein thrombosis and pulmonary embolism.
Thrombosis and haemostasis 1997;78(1):489-96.
1997: PM Kuijer; F Turkstra; Edwin J R Van Beek; JW ten Cate; Harry R Büller
A survey of the diagnostic and therapeutic management of patients with suspected pulmonary embolism in the Netherlands.
The Netherlands journal of medicine 1997;50(6):261-6.
1997: F Turkstra; PM Kuijer; Edwin J R Van Beek; D P M Brandjes; JW ten Cate; Harry R Büller
Diagnostic utility of ultrasonography of leg veins in patients suspected of having pulmonary embolism.
Annals of internal medicine 1997;126(10):775-81.
1997: D P M Brandjes; Harry R Büller; Harriët Heijboer; M V Huisman; M de Rijk; H Jagt; JW ten Cate
Randomised trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis.
Lancet 1997;349(9054):759-62.
1996: Philip W Friederich; Bernd-Jan Sanson; Paolo Simioni; S Zanardi; Menno V Huisman; I Kindt; Paolo Prandoni; Harry R Büller; Antonio Girolami; Martin H Prins
Frequency of pregnancy-related venous thromboembolism in anticoagulant factor-deficient women: implications for prophylaxis.
Annals of internal medicine 1996;125(12):955-60.
1996: BC Michel; R J Seerden; Edwin J R Van Beek; Harry R Büller; Frans F H Rutten
[Costs of diagnosis and treatment for pulmonary embolism lower due to application of consensus strategy].
Nederlands tijdschrift voor geneeskunde 1996;140(37):1864-8.
1996: John Meenan; D W Hommes; M Mevissen; S Dijkhuizen; H Soule; M Moyle; Harry R Büller; F W ten Kate; G N J Tytgat; Sander J H van Deventer
Attenuation of the inflammatory response in an animal colitis model by neutrophil inhibitory factor, a novel beta 2-integrin antagonist.
Scandinavian journal of gastroenterology 1996;31(8):786-91.
1996: BC Michel; R J Seerden; Frans F H Rutten; Edwin J R Van Beek; Harry R Büller
The cost-effectiveness of diagnostic strategies in patients with suspected pulmonary embolism.
Health economics 1996;5(4):307-18.
1996: F Turkstra; Edwin J R Van Beek; JW ten Cate; Harry R Büller
Reliable rapid blood test for the exclusion of venous thromboembolism in symptomatic outpatients.
Thrombosis and haemostasis 1996;76(1):9-11.
1996: H C Knipscheer; C C Boelen; John J P Kastelein; Denise Van Diermen; B E Groenemeijer; A van den Ende; Harry R Büller; Henk D Bakker
Short-term efficacy and safety of pravastatin in 72 children with familial hypercholesterolemia.
Pediatric research 1996;39(5):867-71.
1996: M T Nurmohamed; A M van Riel; C M Henkens; Maria M W Koopman; G T Que; P d'Azemar; Harry R Büller; JW ten Cate; J A Hoek; Jan van der Meer; C van der Heul; A G Turpie; S Haley; A Sicurella; M Gent
Low molecular weight heparin and compression stockings in the prevention of venous thromboembolism in neurosurgery.
Thrombosis and haemostasis 1996;75(2):233-8.
1996: Edwin J R Van Beek; Jim A Reekers; D A Batchelor; D P M Brandjes; Harry R Büller
Feasibility, safety and clinical utility of angiography in patients with suspected pulmonary embolism.
European radiology 1996;6(4):415-9.
1996: B J Biemond; Philip W Friederich; Marcel Levi; G P Vlasuk; Harry R Büller; JW ten Cate
Comparison of sustained antithrombotic effects of inhibitors of thrombin and factor Xa in experimental thrombosis.
Circulation 1996;93(1):153-60.
1995: Edwin J R Van Beek; P M Kuyer; B E Schenk; D P M Brandjes; JW ten Cate; Harry R Büller
A normal perfusion lung scan in patients with clinically suspected pulmonary embolism. Frequency and clinical validity.
Chest 1995;108(1):170-3.
1995: Bart J Biemond; Marcel Levi; Hugo ten Cate; Tom van der Poll; Harry R Büller; C Erik Hack; JW ten Cate
Plasminogen activator and plasminogen activator inhibitor I release during experimental endotoxaemia in chimpanzees: effect of interventions in the cytokine and coagulation cascades.
Clinical science (London, England : 1979) 1995;88(5):587-94.
1995: Bart J Biemond; Marcel Levi; Hugo ten Cate; H R Soule; L D Morris; D L Foster; C A Bogowitz; Tom van der Poll; Harry R Büller; JW ten Cate
Complete inhibition of endotoxin-induced coagulation activation in chimpanzees with a monoclonal Fab fragment against factor VII/VIIa.
Thrombosis and haemostasis 1995;73(2):223-30.
1995: Maria M W Koopman; Harry R Büller; JW ten Cate
Diagnosis of recurrent deep vein thrombosis.
Haemostasis 1995;25(1-2):49-57.
1994: Edwin J R Van Beek; M Levi; Jim A Reekers; C E Hack; Harry R Büller; JW ten Cate
Increased plasma levels of PAI-1 after administration of nonionic contrast medium in patients undergoing pulmonary angiography.
Radiology 1994;193(3):821-3.
1994: Edwin J R Van Beek; M A von der Möhlen; JW ten Cate; D P M Brandjes; Harry R Büller
Antithrombin III concentrate in the treatment of DIC: a retrospective follow-up study.
The Netherlands journal of medicine 1994;45(5):206-10.
1994: Bart J Biemond; Marcel Levi; M T Nurmohamed; Harry R Büller; JW ten Cate
Additive effect of the combined administration of low molecular weight heparin and recombinant hirudin on thrombus growth in a rabbit jugular vein thrombosis model.
Thrombosis and haemostasis 1994;72(3):377-80.
1994: M T Nurmohamed; Harry R Büller; JW ten Cate
Physiological changes due to age. Implications for the prevention and treatment of thrombosis in older patients.
Drugs & aging 1994;5(1):20-33.
1994: L M Jongbloets; Anthonie W A Lensing; M M Koopman; Harry R Büller; JW ten Cate
Limitations of compression ultrasound for the detection of symptomless postoperative deep vein thrombosis.
Lancet 1994;343(8906):1142-4.
1994: Tom van der Poll; Marcel Levi; C Erik Hack; Hugo ten Cate; Sander J H van Deventer; A J Eerenberg; Els R de Groot; J Jansen; H Gallati; Harry R Büller
Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees.
The Journal of experimental medicine 1994;179(4):1253-9.
1994: Edwin J R Van Beek; Harry R Büller; D P M Brandjes; G C Rutten; JW ten Cate
Diagnosis of clinically suspected pulmonary embolism: a survey of current practice in a teaching hospital.
The Netherlands journal of medicine 1994;44(2):50-5.
1994: Tom van der Poll; Marcel Levi; Sander J H van Deventer; Hugo ten Cate; B L Haagmans; Bart J Biemond; Harry R Büller; C Erik Hack; JW ten Cate
Differential effects of anti-tumor necrosis factor monoclonal antibodies on systemic inflammatory responses in experimental endotoxemia in chimpanzees.
Blood 1994;83(2):446-51.
1994: Marcel Levi; Hugo ten Cate; K A Bauer; Tom van der Poll; T S Edgington; Harry R Büller; Sander J H van Deventer; C Erik Hack; JW ten Cate; R D Rosenberg
Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees.
The Journal of clinical investigation 1994;93(1):114-20.
1993: H Heijboer; Harry R Büller; Anthonie W A Lensing; A G Turpie; L P Colly; JW ten Cate
A comparison of real-time compression ultrasonography with impedance plethysmography for the diagnosis of deep-vein thrombosis in symptomatic outpatients.
The New England journal of medicine 1993;329(19):1365-9.
1993: Francesco Gianese; M T Nurmohamed; BP Imbimbo; Harry R Büller; René Berckmans; JW ten Cate
The pharmacokinetics and pharmacodynamics of dermatan sulphate MF701 during haemodialysis for chronic renal failure.
British journal of clinical pharmacology 1993;35(3):335-9.
1993: J M Prins; Harry R Büller; Ed J Kuijper; Rinze A Tange; Peter Speelman
Once versus thrice daily gentamicin in patients with serious infections.
Lancet 1993;341(8841):335-9.
1993: Edwin J R Van Beek; MM Tiel-van Buul; Harry R Büller; EA van Royen; JW ten Cate
The value of lung scintigraphy in the diagnosis of pulmonary embolism.
European journal of nuclear medicine 1993;20(2):173-81.
1993: Harry R Büller
Hirudin in the treatment of arterial and venous thrombotic diseases: a new perspective.
Zeitschrift für Kardiologie 1993;82 Suppl 2():81-2.
1992: Marcel Levi; J Wilmink; Harry R Büller; Janto Surachno; JW ten Cate
Impaired fibrinolysis in cyclosporine-treated renal transplant patients. Analysis of the defect and beneficial effect of fish-oil.
Transplantation 1992;54(6):978-83.
1992: D P M Brandjes; H Heijboer; Harry R Büller; M de Rijk; H Jagt; JW ten Cate
Acenocoumarol and heparin compared with acenocoumarol alone in the initial treatment of proximal-vein thrombosis.
The New England journal of medicine 1992;327(21):1485-9.
1992: Paolo Prandoni; Anthonie W A Lensing; Harry R Büller; A Cogo; Martin H Prins; A M Cattelan; S Cuppini; F Noventa; JW ten Cate
Deep-vein thrombosis and the incidence of subsequent symptomatic cancer.
The New England journal of medicine 1992;327(16):1128-33.
1992: H Heijboer; A Cogo; Harry R Büller; Paolo Prandoni; JW ten Cate
Detection of deep vein thrombosis with impedance plethysmography and real-time compression ultrasonography in hospitalized patients.
Archives of internal medicine 1992;152(9):1901-3.
1992: M T Nurmohamed; F R Rosendaal; Harry R Büller; E Dekker; D W Hommes; J P Vandenbroucke; E Briët
Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis.
Lancet 1992;340(8812):152-6.
1992: H Heijboer; L M Jongbloets; Harry R Büller; Anthonie W A Lensing; JW ten Cate
Clinical utility of real-time compression ultrasonography for diagnostic management of patients with recurrent venous thrombosis.
Acta radiologica (Stockholm, Sweden : 1987) 1992;33(4):297-300.
1992: Tom van der Poll; Sander J H van Deventer; G Pasterkamp; Jan A van Mourik; Harry R Büller; JW ten Cate
Tumor necrosis factor induces von Willebrand factor release in healthy humans.
Thrombosis and haemostasis 1992;67(6):623-6.
1992: H Heijboer; J S Ginsberg; Harry R Büller; Anthonie W A Lensing; L P Colly; J Wouter ten Cate
The use of the D-dimer test in combination with non-invasive testing versus serial non-invasive testing alone for the diagnosis of deep-vein thrombosis.
Thrombosis and haemostasis 1992;67(5):510-3.
1992: Paolo Prandoni; Anthonie W A Lensing; Harry R Büller; M Carta; A Cogo; M Vigo; Dario Casara; A Ruol; JW ten Cate
Comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal deep-vein thrombosis.
Lancet 1992;339(8791):441-5.
1992: D W Hommes; A Bura; L Mazzolai; Harry R Büller; JW ten Cate
Subcutaneous heparin compared with continuous intravenous heparin administration in the initial treatment of deep vein thrombosis. A meta-analysis.
Annals of internal medicine 1992;116(4):279-84.
1992: Tom van der Poll; Sander J H van Deventer; C Erik Hack; Gertjan Wolbink; Lucien A Aarden; Harry R Büller; JW ten Cate
Effects on leukocytes after injection of tumor necrosis factor into healthy humans.
Blood 1992;79(3):693-8.
1992: Anthonie W A Lensing; Harry R Büller; Paolo Prandoni; D Batchelor; A H Molenaar; A Cogo; M Vigo; P M Huisman; JW ten Cate
Contrast venography, the gold standard for the diagnosis of deep-vein thrombosis: improvement in observer agreement.
Thrombosis and haemostasis 1992;67(1):8-12.
1992: K de Boer; Harry R Büller; JW ten Cate; Marcel Levi
Deep vein thrombosis in obstetric patients: diagnosis and risk factors.
Thrombosis and haemostasis 1992;67(1):4-7.
1992: J A Hoek; M T Nurmohamed; K J Hamelynck; R K Marti; H C Knipscheer; Hugo ten Cate; Harry R Büller; H N Magnani; JW ten Cate
Prevention of deep vein thrombosis following total hip replacement by low molecular weight heparinoid.
Thrombosis and haemostasis 1992;67(1):28-32.
1992: Marcel Levi; C Erik Hack; J P de Boer; D P M Brandjes; Harry R Büller; JW ten Cate
Contact system dependent fibrinolytic activity in vivo: observations in healthy subjects and factor XII deficient patients.
Agents and actions. Supplements 1992;38 ( Pt 2)():292-8.
1991: D P M Brandjes; B E Schenk; Harry R Büller; JW ten Cate
Management of disseminated intravascular coagulation in obstetrics.
European journal of obstetrics, gynecology, and reproductive biology 1991;42 Suppl():S87-9.
1991: Marcel Levi; C Erik Hack; J P de Boer; D P M Brandjes; Harry R Büller; JW ten Cate
Reduction of contact activation related fibrinolytic activity in factor XII deficient patients. Further evidence for the role of the contact system in fibrinolysis in vivo.
The Journal of clinical investigation 1991;88(4):1155-60.
1991: Marcel Levi; Anthonie W A Lensing; Harry R Büller; Paolo Prandoni; G Dooijewaard; S Cuppini; JW ten Cate
Deep vein thrombosis and fibrinolysis. Defective urokinase type plasminogen activator release.
Thrombosis and haemostasis 1991;66(4):426-9.
1991: Tom van der Poll; Marcel Levi; Harry R Büller; Sander J H van Deventer; J P de Boer; C Erik Hack; JW ten Cate
Fibrinolytic response to tumor necrosis factor in healthy subjects.
The Journal of experimental medicine 1991;174(3):729-32.
1991: Paolo Prandoni; Anthonie W A Lensing; Harry R Büller; M Carta; M Vigo; A Cogo; S Cuppini; JW ten Cate
Failure of computerized impedance plethysmography in the diagnostic management of patients with clinically suspected deep-vein thrombosis.
Thrombosis and haemostasis 1991;65(3):233-6.
1991: Paolo Prandoni; Anthonie W A Lensing; Menno V Huisman; Jan J C Jonker; M Vigo; J J Borm; Harry R Büller; Ah Kang Sing; M Carta; JW ten Cate
A new computerized impedance plethysmograph: accuracy in the detection of proximal deep-vein thrombosis in symptomatic outpatients.
Thrombosis and haemostasis 1991;65(3):229-32.
1991: F R Rosendaal; H Heijboer; E Briët; Harry R Büller; D P M Brandjes; K de Bruin; D W Hommes; Jan P Vandenbroucke
Mortality in hereditary antithrombin-III deficiency--1830 to 1989.
Lancet 1991;337(8736):260-2.
1991: Tom van der Poll; Sander J H van Deventer; Harry R Büller; Augueste Sturk; JW ten Cate
Comparison of the early dynamics of coagulation activation after injection of endotoxin and tumor necrosis factor in healthy humans.
Progress in clinical and biological research 1991;367():55-60.
1991: H Heijboer; JW ten Cate; Harry R Büller
Diagnosis of venous thrombosis.
Seminars in thrombosis and hemostasis 1991;17 Suppl 3():259-68.
1990: H Heijboer; D P M Brandjes; Harry R Büller; Augueste Sturk; JW ten Cate
Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep-vein thrombosis.
The New England journal of medicine 1990;323(22):1512-6.
1990: Anthonie W A Lensing; P Prandoni; Harry R Büller; Dario Casara; A Cogo; JW ten Cate
Lower extremity venography with iohexol: results and complications.
Radiology 1990;177(2):503-5.
1990: Anthonie W A Lensing; M M Levi; Harry R Büller; Paolo Prandoni; M Vigo; G Agnelli; L Lupatelli; Menno V Huisman; JW ten Cate
Diagnosis of deep-vein thrombosis using an objective Doppler method.
Annals of internal medicine 1990;113(1):9-13.
1990: Tom van der Poll; Harry R Büller; Hugo ten Cate; C H Wortel; K A Bauer; Sander J H van Deventer; C Erik Hack; Hans P Sauerwein; R D Rosenberg; JW ten Cate
Activation of coagulation after administration of tumor necrosis factor to normal subjects.
The New England journal of medicine 1990;322(23):1622-7.
1989: J A Hoek; M T Nurmohamed; JW ten Cate; Harry R Büller; H C Knipscheer; K J Hamelynck; R K Marti; Augueste Sturk
Thrombin-antithrombin III complexes in the prediction of deep vein thrombosis following total hip replacement.
Thrombosis and haemostasis 1989;62(4):1050-2.
1989: Harry R Büller; JW ten Cate
Acquired antithrombin III deficiency: laboratory diagnosis, incidence, clinical implications, and treatment with antithrombin III concentrate.
The American journal of medicine 1989;87(3B):44S-48S.
1989: M V Huisman; Harry R Büller; JW ten Cate; E A van Royen; J Vreeken; M J Kersten; B Bakx
Unexpected high prevalence of silent pulmonary embolism in patients with deep venous thrombosis.
Chest 1989;95(3):498-502.
1989: Anthonie W A Lensing; Paolo Prandoni; D P M Brandjes; P M Huisman; M Vigo; G Tomasella; J Krekt; J Wouter Ten Cate; Menno V Huisman; Harry R Büller
Detection of deep-vein thrombosis by real-time B-mode ultrasonography.
The New England journal of medicine 1989;320(6):342-5.
1988: M V Huisman; Harry R Büller; JW ten Cate
Utility of impedance plethysmography in the diagnosis of recurrent deep-vein thrombosis.
Archives of internal medicine 1988;148(3):681-3.
1987: Augueste Sturk; W M Morrien-Salomons; M V Huisman; J J Borm; Harry R Büller; JW ten Cate
Analytical and clinical evaluation of commercial protein C assays.
Clinica chimica acta; international journal of clinical chemistry 1987;165(2-3):263-70.
1986: M V Huisman; Harry R Büller; JW ten Cate; J Vreeken
Serial impedance plethysmography for suspected deep venous thrombosis in outpatients. The Amsterdam General Practitioner Study.
The New England journal of medicine 1986;314(13):823-8.
1985: M V Huisman; Harry R Büller; D C Basart; JW ten Cate
A comparison of impedance plethysmography and strain gauge plethysmography in the diagnosis of deep venous thrombosis in symptomatic outpatients.
Thrombosis research 1985;40(4):533-41.
1984: D C Basart; M V Huisman; Harry R Büller; P A Ockelford; JW ten Cate; A Grasboer; J W Marsman; J Vreeken
Evaluation of impedance plethysmography as a single non-invasive test for the diagnosis of clinically suspected deep vein thrombosis.
The Netherlands journal of medicine 1984;27(6):197-201.